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Executive Summary 
In the wake of socioeconomic development, changing demographics towards ageing 
populations and the expatiation of non-communicable diseases put additional strains and new 
challenges unto health services and disease management in low-income countries. Chronic 
Obstructive Pulmonary Disease (COPD) is by the WHO Global Burden of Disease Study 
projected to rank as third leading cause of death worldwide in 2020, though studies 
concerning prevalence of COPD and presence of risk factors in low-income settings are yet 
rare. The expected frequency and burden of COPD is however anticipated to be of same 
magnitude in these countries, where exposures to occupational and domestic hazards are 
considerable, as for infections and morbidities, influences known to be detrimental to 
respiratory health. Assessing prevalence and diagnosis is an important step towards clinical 
management and awareness regarding implementation of prevention initiatives. A necessity in 
diagnosis of COPD and measuring disease severity is the use of reference values for normal 
lung function. Adhering to American Thoracic Society (ATS) recommendations, such 
prediction equations should be based on healthy people with the same anthropometric 
characteristics and ethnic origin as the subjects being tested. This study aims at deriving 
reference values of a healthy adult suburban population in Dar Es Salaam, Tanzania, and to 
estimate prevalence of COPD from a random sample of the population. 
The study is based on a descriptive cross-sectional design. The source population comprised 
all adults above the age of 15 in Kinondoni district. Estimating prevalence to 15 % and 
accounting for reduced precision due to cluster sampling procedure, the sample size required 
was set to 300 participants. Approval was obtained from the Ethical Committee of Western 
Norway (REK-Vest) and the Medical Research Coordinating Committee of the National 
Institute for Medical Research (MRCC). Subjects within the age-span examined and who 
were willing to participate, were eligible for participation. A total of 365 subjects were 
enrolled in the study. Sub-selection to the reference sample and for generation of prediction 
equations were based on ATS recommendations, where subjects with negative responses to 
core questions from ATS-DLD regarding respiratory symptoms and doctor diagnosed 
heart/chest illnesses were selected, providing their spirometric data met ATS criteria. 
Lung volumes was tested using the ndd EasyOne spirometer, and the following parameters 
were measured; peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), 
forced expiratory volume in six seconds (FEV6) and the ratio of these two measurements 
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(FEV1/FEV6). All spirograms were reviewed by an experienced chest physician, adhering to 
ATS acceptability and reproducibility criteria for selection of best pulmonary function curve. 
Anthropometric data, including weight, standing height and sitting height were collected, and 
age was recorded as birth-date or as mid year in the year of birth. Respiratory symptoms were 
recorded using the ATS-DLD validated questionnaire, and questions regarding socioeconomic 
conditions were derived from a culture specific questionnaire used in the Tanzania 
Demographic Health Survey from 1999 and 2002.  
Prevalence of COPD was estimated according to the Global initiative for chronic Obstructive 
Lung Disease (GOLD) and ATS criteria, and severity was determined by GOLD disease 
stages. 
Based on the inclusion criteria, a total of 150 subjects, 52 men (32,7 %) and 98 women (47,6 
%) were selected to the reference value group. Median age for men and women in the 
reference sample was 34 years. The spirometric parameters FEV1, FEV6, FEV1/FEV6 and 
PEF were regressed against sample mean age, height and weight, and the models were 
assessed in terms of whether a linear or curvilinear prediction produced best fit for the present 
data. In the male strata, an exponential model was selected as regression equation for all of 
the spirometric variables, with the exception of prediction of PEF when sitting height was 
independent variable, where a linear model was applied. For women, a linear model was 
chosen in further analyses, except for the prediction equations for PEF, where an exponential 
equation best fitted the data. For women, weight was retained in the final model when 
standing height was part of the independent variables and regressed against PEF. For the other 
spirometric variables, weight was non-significant, and was removed from the equations in 
further analyses. Height, and height square in the exponential equations for men and women, 
entered all the regression models with the exception of the model predicting FEV1/FEV6, as 
it did not provide a significant contribution to the variance of the dependent variables. All the 
spirometric parameters were negatively related to age, and all increased with height, with 
exception of FEV1/FEV6. The lower limit of normal (LLN) is presented as – 1,645 x SEE 
which is the age and height specific, estimated 5th percentile for the reference sample. The 
reference equations derived from our study do not allow direct comparison with previously 
published predictions due to differences in source populations and for the effects of altitude, 
however, on average, our equations generated lower reference values. When comparing our 
predictions to those published by Mustafa in 1977, no secular changes in FEV1 values could 
be traced. .   
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Both presence of respiratory symptoms and illnesses were more frequently reported among 
the female participants, though considerable in both sexes.  
Regarding questions on smoking exposure, a proportion of 14,0 % of the study population 
responded that they were current smokers, and 4,7 % was ex-smokers. Patterns of cigarette 
smoking differed substantially between the sexes, where the proportion of current smokers 
was considerably higher for men (30,2 %) than for women (1,5 %).  
Prevalence of COPD when applying a fixed cut off ratio of FEV1/FEV6 < 0,73, was 12,6 %, 
and it was equally distributed among men (13,9 %) and women (11,5 %). Prevalence of 
COPD when classified as below the lower limit of normal was 7,9 %, also equally distributed 
with 6,9 % and 8,7 % of men and women respectively. In our study, prevalence of stage I and 
II COPD was 6,1 % and 5,8 % respectively.  
Direct logistic regression was conducted to assess the impact of certain determinants on 
COPD. Separate analyses were carried out for GOLD and ATS/ERS defined COPD. The 
multivariate models contained the following independent variables; sex, age, domestic 
exposure, occupational exposure, smoking status and socioeconomic position.  When GOLD 
defined COPD was dependent variable, the following covariates made a statistically 
significant contribution to the model; being ex-smoker, (p = 0,01), and age (p < 0,0005). The 
strongest predictor was ex-smoker, with an odds ratio (OR) of 5,37. In the model using the 
ATS defined COPD prevalence, the independent variable, ex-smoker was still significant (p = 
0,004) with an OR of 7,92. In addition, domestic exposure made a statistically significant 
contribution to the variance of the model (p = 0,013). However, the OR was less than 1 (0,19), 
indicating a negative association. 
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Introduction 
“Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with 
some significant extrapulmonary effects that may contribute to the severity in individual 
patients. Its pulmonary component is characterized by airflow limitation that is not fully 
reversible. The airflow limitation is usually progressive and associated with an abnormal 
inflammatory response of the lung to noxious particles or gases”.  
 
This is the clinical definition of COPD recommended by the Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) (1).  According to the same guidelines, COPD is 
determined by use of a fixed percentage of spirometric predicted values, with airflow 
limitation defined as a forced expiratory volume in one second/forced vital capacity 
(FEV1/FVC) ratio less than 70 % (1, 2, 3). When applying ATS1/ERS2 guidelines, ventilatory 
obstructivity is defined as a reduced FEV1/FVC ratio below the statistically derived fifth 
percentile of the predicted value, and this lower limit of normal is used as a cut off to 
determine proportion of responders with COPD (3, 4, 5). The WHO Global Burden of 
Disease Study estimated COPD to rank as the fifth leading cause of death in 2001, and 
predicts the disease to be the third leading cause of death worldwide in 2020 (6). The 
expected increase in mortality is brought forth by both changing demographics, with ageing 
populations reaching the stage of developing chronic diseases, as well as an anticipated 
increase of cigarette smoking in many African and Asian countries (1, 6). 
  
Besides cigarette smoking, occupational pollutants as vapours, irritants and fumes are found 
to be important contributing factors in development of COPD (1, 2, 4). Several studies within 
occupational medicine have examined the association between environmental exposures and 
respiratory impairment (7, 8, 9). Some researchers have also shown an additive effect of 
smoking and occupational pollutants on mortality from COPD (1, 7). Additional risk factors, 
like indoor pollution from solid fuels for cooking and heating, have been thought to increase 
the prevalence of COPD, especially among women in developing countries (1, 6, 10, 11). 
Three billion people in the world, mainly in the Middle East, Africa and Asia, use biomass 
fuels and coal as their main source of energy. Many of them live in poorly ventilated houses 
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(1). This illustrates the interconnection of respiratory symptoms and socioeconomic factors 
that besides living conditions and increased levels of indoor pollution, also influence exposure 
to potential environmental hazards and episodes of respiratory illness (4, 6, 8). Socioeconomic 
status is thus thought to be an important determinant of lung function (4, 6). HIV infection has 
been shown to accelerate the onset of smoking-related emphysema, and might be an important 
cofactor in the development and burden of COPD (12). This reinforces the thought of COPD 
as both underreported and under-diagnosed in low-income countries, none the less causing 
high morbidity and mortality in poorly resourced populations, with less access to health care 
and preventive actions.  
 
The fact that COPD among other non communicable diseases is growing worldwide, putting 
strains on already heavily pressured populations, justifies the need to investigate the burden of 
obstructive lung disease in low-income countries, and to increase awareness, implement 
prevention strategies and improve management of this disease. Measurement of lung function 
and prevalence of obstructive lung diseases in the catchment area and age group for the 
present study is important, as there is no recent published data on respiratory function in the 
general population in Dar Es Salaam, Tanzania. 
 
 This study has been conducted under the framework of collaborations between National 
Institute for Medical Research (NIMR), Tanzania, and the University of Bergen. The two 
partners have a Memorandum Of Understanding (MOU) whereby a number of Tanzanian 
scientists have conducted several projects for their Master and PhD degrees. The study 
presented here is one in the series of training projects that are conducted under this framework 
and the project has investigated an important health problem which is defined in the National 
Health Research Agenda of Tanzania. In addition, the project will contribute and complement 
to NIMR, supported by the International Association of National Public Institute (IANPHI), 
with an overall goal of developing an evidence-based approach to establishing national 
surveillance for Non Communicable Diseases and creating the foundation for a national 
programme through training and exchange. 
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Assessing COPD 
Quantifying prevalence and assessing diagnosis and severity of COPD is a challenge in low- 
income countries and in epidemiological field work, where resources are scarce and there is 
less availability of appropriate equipment and tools needed to fully apply standardized and 
recommended guidelines (1, 2, 3, 5). GOLD acknowledges this in its report, emphasizing that 
in areas lacking access to state-of-the-art diagnostic tools, diagnosis should be made with the 
equipment available (13). The Burden of Obstructive Lung Disease (BOLD) Initiative 
addresses the scarce documentation of prevalence, true burden and key risk factors across 
countries (10). In one of their studies, involving 12 different countries, Cape Town, South 
Africa had by far the highest prevalence of clinically manifested COPD at 12 %. By 
comparison Bergen, Norway, had an estimated prevalence of 7 % (13). The South African 
study site revealed high numbers of participants with previous tuberculosis in addition to 
extensive exposures of occupational pollutants and cigarette smoking (13). This pattern of co-
morbidity and presence of risk factors fits well in other sub-Saharan countries, and indicates 
that the expected frequencies of COPD in other African countries are of similar magnitude, 
though this has not yet been established. 
 
Lung function measurements 
In accordance with GOLD and ATS guidelines, the following basic parameters are frequently 
used in lung function testing and in assessing respiratory diseases; forced expiratory volume 
in one second (FEV1), forced vital capacity (FEV6) and the ratio of these two measurements 
(FEV1/FEV6). Due to increased risk of false-positive diagnosis in the interpretation, it is 
recommended not to include too many indices of lung function in the testing (1, 4, 5). The 
selected parameters are important in identifying obstructive airflow limitation, and FEV1 and 
FEV1/FEV6 are also shown to be independent predictors of mortality from respiratory 
diseases (2, 4, 5, 13, 14, 15, 16).  
A necessity in assessment of COPD and disease severity is the use of reference values for 
normal lung function. According to ATS recommendations, selection of such prediction 
equations should be based on healthy populations sharing the same anthropometric 
characteristics (sex, age and height) and ethnic origin as the subject being tested (11). When 
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compared to Caucasians of European descent, other ethnic groups have shown to have smaller 
static and dynamic lung volumes (4). When measured at same standing height, spirometric 
values derived from White populations tend to over-predict values in Black subjects by 12 % 
for total lung capacity (TLC), forced expiratory volume in one second (FEV1) and forced 
vital capacity (FVC) (4, 11). The practice of using fixed adjustment factors of published 
reference values to control for such ethnic differences is however questioned, and when 
possible, it is recommended to use race specific predictions (11, 17, 18, 19, 20).  
The causality of ethnic differences is not fully accounted for, though it is thought to be partly 
due to differences in body build, and that Blacks have smaller trunk-to-leg ratio than Whites 
(4, 11). Studies have tried to adjust for this by using sitting height as anthropometric measure 
in lung function testing, which reduces, but not eliminates the differences between Blacks and 
Whites (11, 17, 18, 20, 21). Ethnic differences have also been thought to concur with 
environmental and socioeconomic factors, rather than being merely genetic inherent, a 
connection which makes the selection and use of appropriate reference values even more 
complex (4, 17, 18, 19, 20, 21). Another critique of using ethnic scaling- factors, is the 
inability of such a method to face socio-environmental factors as nutrition, growth and health 
status as influences of lung function , and how these determinants are subject to development 
and change throughout the decades, a phenomenon known as the cohort-effect (4, 11, 21, 22, 
23, 24). Several studies of normal lung function on the African continent have pointed out 
such a secular trend, where higher spirometric values have been measured in more recent 
studies (19, 20, 24, 25, 26). This has made researchers aware of the need of reference values 
to be updated at regular intervals, preferably every decade (4, 11, 26). Even though there are 
several published reference values derived from healthy African populations (19, 20, 22, 25, 
26, 27), they all acknowledge their limitations in terms on generalisability across countries. 
Important geographic determinants like altitude has been shown to explain some of the 
differences in lung function within populations on the African continent (19). Spirometric 
values of forced expiratory flows are increased at high altitudes (above 1,500 m), and it has 
been shown that people living at higher altitudes have larger lung volumes (4). Selection of 
study population, whether randomly selected from a community, or through a workforce has 
further been demonstrated to influence the prediction equations derived. Occupation based 
samples of men and women have had higher lung volumes than those derived from 
community source, a bias known as the healthy worker effect (19, 20). The different 
determinants and factors contributing to lung function, and the possible bias in the process of 
deriving reference values, enhance the importance of appropriate prediction equations in the 
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diagnosis of COPD and disease severity. In Tanzania, the work of Mustafa (28) has 
contributed to generation of proper prediction equations in assessment of lung function and 
respiratory diseases.  The present study seeks to update reference values of the general adult 
population of today. 
 
Aims and objectives 
The present study has a twofold aim: To derive reference values of a healthy adult suburban 
population in the district of  Kinondoni,  Dar Es Salaam, Tanzania and to estimate prevalence 
of COPD from a random sample of the population 
 
Specific objectives: 
1 To measure spirometric values of FEV1, FEV6, FEV1/FEV6 ratio and PEF in all study 
   participants 
2 To derive reference values from spirometric measurements of non-symptomatic 
   study subjects 
3 To estimate prevalence of respiratory symptoms based on ATS-DLD4 (American Thoracic 
   Society- Division of Lung Disease) and culture specific questionnaire 
4 To determine prevalence of COPD based on spirometric values according to GOLD and 
ATS diagnostic criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
4
 ATS-DLD: validated respiratory questionnaire 
 14
 
 
Methods 
Study design and participants 
The study is based on a descriptive cross-sectional design. The source population comprised 
all adults above the age of 15 in Kinondoni district, a suburban area of Dar Es Salaam, 
Tanzania, roughly estimated to hold a population of 350,000.  Exact population registries do 
not exist. Participants were recruited by multistage cluster random sampling, and the 
procedure comprised three stages of selection. In the first stage, two out of 27 wards in 
Kinondoni district were selected. At next stage, two of a total of five areas within each ward 
were chosen. In the last stage, four ten-cell leaders were selected from each area, adding up to 
a total of 16 clusters. The term ‘Ten-cell leader’ refers to the smallest administrative unit in 
Tanzania, and one ten-cell leader has the responsibility for approximately 10-12 households 
(29). The number of ten-cell leaders varied in the selected areas; one area held a total of 40 
ten-cell leaders, whereas another comprised 10 ten-cell leaders and the last two areas 
consisted of 8 ten-cell leaders each. The primary sampling unit comprised all households 
under the selected ten-cell leaders.  
Sample size was calculated on the basis of the objective to determine prevalence of COPD, at 
a 95 % confidence interval, and with precision set at 0,05. Assumptions of expected frequency 
of COPD were based on a study in South Africa, showing a prevalence of COPD around 12 % 
(13). Estimating prevalence of COPD to 15% and accounting for reduced precision due to 
cluster sampling through use of a design effect at 1.55, the minimum sample size required was 
calculated to 300 participants. The presented formula was applied in the sample size 
calculation (30) 
 
    
Where n = sample size 
Z = level of confidence 
P = expected prevalence 
d = precision, here set at 0.05 
 
                                                 
5
 Inflation factor of 1,5 obtained on basis of mean cluster size of 25 individuals and an intra correlation   
coefficient of 0,02. 
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 Recruiting study subjects was initiated by first informing the randomly selected ten-cell 
leaders about the aim of the study, and seeking their approval to collect the necessary data. 
Next, a mobile testing team carried out a knock-on-door approach to the households under 
their selected ten-cell leaders. Subjects within the age-span examined and who were willing to 
participate, were included in the study. Selection of subjects eligible for generating reference 
values followed ATS recommendations, where subjects with negative responses to core 
questions from ATS-DLD regarding respiratory symptoms and doctor diagnosed heart/chest 
illnesses were selected, providing their spirometric data met ATS criteria (4, 31). Questions 
regarding self reported occupational exposures were excluded from the stratification because 
they yielded unreliable information. However, duration of symptoms like cough, phlegm, 
wheezing and breathlessness were accounted for, as were past or present history of smoking 
and respiratory illnesses like chronic bronchitis, emphysema, asthma, tuberculosis, doctor 
diagnosed heart problem and high blood pressure confirmed by a doctor. 
 
Data collection methods: definitions and measurement 
Spirometry  
The spirometric testing was performed using the ndd EasyOne spirometer (ndd 
Medizintechnik AG), which has proven to be suitable in field work as it operates on batteries 
and requires no calibration, yet achieving a high degree of accuracy and reliability (10). The 
following parameters were measured; peak expiratory flow (PEF), forced expiratory volume 
in one second (FEV1), and forced expiratory volume in six seconds (FEV6). In the present 
study FEV6 was chosen over FVC, as it has been shown to be advantageous due to less 
exhalation time, implying both shorter coaching time as well as reduced physical discomfort 
for the participants. It has also been demonstrated to display less test variability when 
compared to FVC (10, 14, 15, 16). All study subjects performed a minimum of three and a 
maximum of eight tests, and the best FEV1, FEV6 and PEF were selected and used in further 
analysis. The spirometric testing was performed by trained assistants following a standardized 
procedure adherent to ATS/ERS guidelines (4, 31). The test subjects performed spirometry 
without nose clips, and sitting position were allowed if participants found the maneuver in 
standing position to be exhausting. All spirograms were reviewed by an experienced chest 
physician, where ATS acceptability and reproducibility criteria were followed for selection of 
best pulmonary function curve; forced exhalation time should exceed a minimum of 6 seconds 
or show a plateau of the volume-time graph. Further each participant should display at least 
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two acceptable reproducible maneuvers with both FEV1 and FEV6 within 200 ml and with 
absence of cough during the first second of the maneuvers (31).  
 
Anthropometry 
Anthropometric data, including weight, standing height and sitting height were obtained using 
robust equipment easy to transport in the field. The anthropometric measurements were 
collected by field personnel trained by the author, and the standardized procedure was 
monitored by the principal investigator throughout the data collection.   
The participants’ weights were obtained using a weight scale. Standing height was measured 
using a metal tape-measure and with heels, shoulders and occiput positioned against the tape. 
Sitting height was measured with a tape-measure affixed to a vertical wooden plank with the 
subjects sitting on a firm wooden chair with buttock, shoulder-blades and occiput touching the 
plank. Participants performed the anthropometric measuring barefoot. 
Age was recorded as birth-date or as mid year in the year of birth. The data were transformed 
to age in years in further analysis. 
 
Questionnaire data 
Respiratory symptoms were recorded using the ATS-DLD validated questionnaire, which was 
translated into Swahili, then back-translated to English prior to data collection, to ensure that 
questions and the phrasing used were adherent to the original format (see appendix 1).  
Questions regarding socioeconomic status were derived from a culture specific questionnaire 
used in the Tanzania Demographic Health Survey from 1999 and 2002 (see appendix 2). The 
questionnaire was administered face-to-face by field personnel, trained to reduce information 
bias regarding interview technique, where phrasing of questions, and appropriate wording, 
was enhanced to obtain acceptable intra and inter- observer variability. 
 
Ethical considerations 
Approval was obtained from the Ethical Committee of Western Norway (REK-Vest), and the 
Medical Research Coordinating Committee of the National Institute for Medical Research 
(MRCC). After subjects eligible for participation were informed of the nature and purpose of 
the study, and had given their informed consent, they were enrolled providing inclusion 
criteria were met. Informed consent form is attached in appendix 3.  
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Statistical analysis 
Data regarding demography, respiratory symptoms and socio-environmental conditions 
included all responders. Estimation of normal spirometric values and COPD prevalence 
included study participants with acceptable spirometry only. The data used to generate 
reference values were analyzed using standardized and hierarchical multiple regression 
techniques. Both linear and curvilinear formulae were obtained, and the model best fitted for 
the present data were chosen. The following dependent variables were applied; FEV1, FEV6, 
PEF and FEV1/FEV6, and regressed against the following independent variables; age, height 
and weight. The explanatory variables were assessed in terms of highest contributing R 
statistic, variable significance at p<0.05, partial correlation coefficients and lowest SEE 
values. Outliers were defined as cases that had standardised residual values above 3,0 or 
below -3,0, and were excluded from further analyses. Preliminary analyses were conducted to 
ensure no violation of the assumption of normality, linearity and multicollinearity. Prediction 
equations were estimated separately for men and women. The lower limit of normal (LLN) 
was defined as the 5th percentile, estimated as 1,645 × SEE, for each of the dependent 
variables. The FEV1/FEV6 ratio did not perfectly match a Gaussian distribution, and 
logarithm and square root transformation were conducted to assess whether the proportion of 
skewness decreased. As the distribution still showed some deviation from the normal curve 
and the standard error of estimate was nearly identical to the non log transformed, the non log 
transformed FEV1/FEV6 was selected in further analyses. 
Reference values generated from the present study were compared to previously published 
predictions by use of paired t-tests, and the magnitude of mean differences was obtained by 
Eta squared calculations. The Independent-Sample T-test was used to compare continuous 
variables, and Pearson Chi square and Wald statistic tests were used to compare group 
differences for categorical variables. Definition and classification of COPD was based on 
ATS and adjusted GOLD criteria, as the present study used FEV1/FEV6 ratio over 
FEV1/FVC in diagnosing (15, 16, 17). Severity was determined by GOLD disease stages (1, 
4, 5). Diagnoses were made on the basis of simple spirometry. The study further defined the 
lower 5 % of the non-symptomatic responders as below the normal limit (LLN) and used this 
as a cut off to determine proportion of responders with COPD (4, 5). Descriptive statistics 
were applied, using frequencies and cross tabulation. Logistic regression analyses were 
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carried out to assess for potential determinants of COPD. The models were adjusted for the 
following variables; sex, age, smoking status, pack years, presence of occupational and 
domestic exposures and level of socioeconomic position. The smoking exposure variable, 
pack years, was computed by dividing the number of cigarettes smoked per day by 20, 
multiplied by number of years smoked. Pack years were computed for both current and ex-
smokers. Smoking status contained the following variables; never smoked ex-smoker and 
current smoker. Occupational exposure was computed by the following variables; worked ≥ 1 
year in dusty work or ever exposed to gas/chemical in work. Domestic exposure was 
constructed by positive responses to question regarding use of biogas and charcoal at home. 
Measures regarding socioeconomic information were collected at individual level, and a 
socioeconomic position variable (SEP index) was constructed according to both economic and 
social dimensions represented by questions regarding level of education, present employment, 
recent work for pay and available money resources derived from the culture specific 
questionnaire used. 
 Logistic regression analyses were generated to estimate odds ratios (OR) with 95 % 
confidence intervals (CI) of COPD. Preliminary analyses were conducted to ensure no 
violation of the assumption of normality and multicollinearity. Both univariate and 
multivariate analyses were conducted. The models were assessed by goodness of fit tests. 
Prevalence estimates were adjusted for multistage cluster sampling during analyses. Each 
participant was given a sampling weight constructed by use of SPSS complex samples 
analysis, where inclusion probabilities at each of the three stages of the sampling procedure 
were added. Variables and differences were assessed in terms of significance at p< 0,05 and 
their 95 % confidence intervals. Descriptive statistics are reported as means and standard 
deviations (SD) when normally distributed, skewed data are expressed in medians and 
percentiles. Calculations were done using the Statistical Package for the Social Sciences 
version 15 (SPSS Inc., Chicago, IL, USA). 
Questionnaire data were double entered, cleaned and coded using Epi data version 3.1 (Centre 
for Disease Control and Prevention, Atlanta, GA, USA), and were exported to SPSS for the 
statistical analyses. The spirometric data were automatically stored in the spirometres used, 
and were electronically exported to SPSS. 
 
 
 
 19
 
 
Results 
Of the 16 selected clusters, 14 were visited, and a total of 365 subjects were enrolled in the 
study, 159 (43,6 %) men and 206 (56,4 %) women. As 135 subjects in the visited households 
were absent at the time of testing, the response rate attained was 74%. However, the 
denominator in this fraction included subjects with unknown eligibility status. Further, 41 
participants were excluded from the study due to conditions contraindicating spirometry 
testing (10): 19 were due to known heart disorder, 15 had undergone chest/abdominal surgery, 
5 were in last trimester of pregnancy, and 2 had undergone eye surgery. Eleven eligible 
subjects refused to participate, giving a cooperation rate of 97 %. After evaluating the 
spirometric measurements, 39 study participants (10,7 %) did not accomplish tests results in 
compliance to ATS criteria, and were excluded from analysis regarding spirometric lung 
indices.                             
 
Synopsis of paper 1 
On the basis of the selection criteria, a total of 150 subjects, 52 men (32,7 %) and 98 women 
(47,6 %) were selected to the reference value group. Median age for the selected men and 
women were 34 years. Bivariate analyses were conducted to evaluate correlations for FEV1, 
FEV6, FEV1/FEV6 and PEF according to sample mean age, height and weight. Age, height 
and sitting height correlated significantly with the dependent variables FEV1 and FEV6 for 
both sexes. For women this was also the case with PEF. FEV1/FEV6 showed no significant 
correlation with height, and neither of the dependent variables correlated with weight in the 
female strata, whereas for men, weight showed a correlation with the FEV1/FEV6 ratio. The 
regression analyses were performed separately for males and females. Assessment whether a 
linear or curvilinear model produced best fit for the present data were done, according to R 
square change and p values. In the male strata, an exponential model was selected as 
regression equation for all of the spirometric variables, with the exception of prediction of 
PEF using sitting height as independent variable, were a linear model was applied. For 
women, a curvilinear model was selected for the prediction of PEF, whereas for the other 
spirometric parameters, a linear model was chosen. For women, weight was retained in the 
final model when standing height was part of the independent variables and regressed against 
PEF. For the dependent variables FEV1, FEV6 and FEV1/FEV6, weight was non-significant, 
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and was removed from the equations in further analyses. Height, and height square in the 
exponential equations for men and women, entered all the regression models with the 
exception of the model predicting FEV1/FEV6, as it did not provide a significant contribution 
to the variance in the present sample and only showed a marginally improvement of the R 
statistics and the corresponding SEE values. Tables 4 and 5, see attached paper 1, summarize 
the prediction equations generated. All the spirometric parameters were negatively related to 
age, and all increased with height, with exception of FEV1/FEV6. The lower limit of normal 
(LLN) is presented as – 1,645 x SEE which is the age and height specific, estimated 5th 
percentile for the reference sample. 
The prediction equations derived from our sample are compared to those of Mokoetle, 
reference values generated from a healthy South African University workforce (21), and with 
Hankinson’s equation (NHANES iii),of African-American above 20 years of  age (32). 
Reference values for the male strata are also compared to Louw equations of Black and White 
South African men (20). Although the reference equations derived from our study do not 
allow direct comparison with previously published predictions due to differences in selection 
of source populations and effects of altitude, on average, our equations generated lower 
reference values. We did not trace any secular changes in FEV1 values when comparing our 
predictions to those of Mustafa from 1977 (28).   
 
Synopsis of paper 2 
Median age was 37 and 34 years for the male and female strata respectively. Age ranged from 
16-79 for men and 15-90 for women. Tables 2 and 3, see paper 2, summarize frequencies and 
proportions of respiratory symptoms and conditions, based on the participants’ responses to 
the ATS-DLD questionnaire. Both presence of symptoms and illnesses were more frequently 
reported among the female participants, though considerable in both sexes.  
In tables 4 and 5, exposures to various risk factors are reported; table 4 presents history and 
magnitude of current/previous smoking among study participants, and table 5 summarizes self 
judged exposure to occupational and domestic pollutants. Men reported more frequently 
exposure of dust and gas/chemicals in work, whereas a higher proportion among women 
reported presence of domestic exposure as biogas and charcoal.  
A total of 14,0 % of the study population responded that they were current smokers, and 4,7 
% was ex-smokers. However, patterns of cigarette smoking differed substantially between the 
sexes, where the proportion of current smokers was considerably higher for men (30,2 %) 
than for women (1,5 %). Also 8,8 % of men, in contrast to only 1,5 % of women,  reported a 
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previously history of smoking. Mean pack-years for current smokers were 8,7 and 6,6 years 
for men and women respectively, whereas mean pack-years for ex-smokers were 7,5 for men, 
and 1,47 for women.  
Prevalence of COPD when applying a fixed cut off ratio of FEV1/FEV6 < 0,73, was 12,6 %, 
and it was equally distributed among men (13,9 %) and women (11,5 %). Prevalence of 
COPD when classified as below the lower limit of normal was 7,9 %, also equally distributed 
with 6,9 % and 8,7 % of men and women respectively. This is presented in table 6, together 
with frequency and proportion of cases of COPD according to GOLD’s four disease severity 
stages. Among the study participants with COPD, only a small fraction were classified in 
stage 3 or higher (0,3 %). The age distribution of COPD cases according to GOLD and 
ATS/ERS are also summarized in table 7. 
Direct logistic regression was performed to assess the impact of certain determinants on 
COPD. Separate analyses were carried out for GOLD and ATS/ERS defined COPD. The 
multivariate models contained the following independent variables; sex, age, domestic 
exposure, occupational exposure, smoking status and socioeconomic position.  The following 
independent variables made a statistically significant contribution to the GOLD defined 
COPD model; being ex-smoker, (p = 0,01), and age (p < 0,0005). The strongest predictor was 
ex-smoker, with an OR of 5,37. When the ATS defined COPD was dependent variable, ex-
smoker was still significant (p = 0,004) with an OR of 7,92. In addition, domestic exposure 
made a statistically significant contribution (p = 0,013). However, the OR was less than 1 
(0,19), indicating a negative association. The logistic regression was not adjusted for complex 
sampling, and the results should be interpreted with caution as the precision of the estimates 
presupposes simple random sampling. Table 8, summarizes the odds ratios generated and 
present them with their corresponding p-values and 95 % confidence intervals.  
 
General discussion 
Discussion of methods 
Selection of source population  
Our study was conducted in Dar Es Salaam, which is situated at coastal level in Tanzania. The 
source population comprised adults above the age of 15 in Kinondoni district, a suburban area 
of Dar Es Salaam, thus the sample was derived from a community source. Both altitude and 
type of source population are found to explain some of the variability in spirometric 
measurements across studies. By using a workforce to generate a study sample, a bias, known 
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as the healthy-worker effect, is thought to generate higher spirometric values. Both Mokoetle 
and Louw used a workforce as source population to generate their reference values (20, 21). 
Both studies were conducted in Johannesburg, South Africa, which is situated 2000 m above 
sea level. According to White et al, this can account for up to 400 ml differences in 
spirometric measurements (19). Our study generated lower spirometric values when compared 
to those of Mokoetle and Louw. When applying Mustafa prediction equations from 1977, 
derived from a northern male Sudanese population and also tested to fit a Tanzanian 
population, this generated similar predicted values for FEV1 as in our study (28). The 
Sudanese site was situated at 400 m altitude, and the sample was derived from an urban 
community source. This raise questions to what extent secular changes, and the bias known as 
the cohort effect influence on the spirometric measurements, though possible differences in 
socio-environmental conditions for the study populations generating the reference values have 
been thought to influence lung function. On the other hand, the present sample size might not 
been sufficiently large to detect differences in lung volumes according to changes in 
determinants as nutrition, health status and environmental factors. The study also failed to 
point out any interconnectedness between lung volumes and socioeconomic factors.   
In accordance with the Barker Fetal Origins of Disease hypothesis, in utero under-nutrition is 
thought to result in permanent detrimental changes associated with an increased susceptibility 
of developing chronic diseases later in life (33). Normal lung growth is found to be related to 
exposures during gestation and childhood, and a reduced attained lung function is associated 
with an increased risk of developing COPD. Researchers have also found a relation between 
birth weight and FEV1 in adulthood. Whether this applies to our study population is 
unknown.   
 
Sample size  
The sample size was calculated at a 95 % confidence level, with precision set at 0.05, and 
assumptions of expected frequency of COPD to 15%. In order to allow for reduced precision 
due to a cluster sampling – technique, and assurance of not making erroneous conclusions 
caused by variation or error in results, a design effect at 1.5 was applied. This inflation factor 
was obtained anticipating a mean cluster size of 25 individuals and an intra correlation 
coefficient of 0,02. On the basis of these calculations, the minimum sample size required was 
300 participants. The study sample was selected randomly, through a multistage cluster 
technique. As the prevalence of COPD in our study was 12,7 % using the fixed ratio, and  
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7,9 % when applying the lower limit of normal, the study had sufficient precision, as the 
calculated frequency was 15 %. However, the available sample in the non-symptomatic group 
was small, particularly in the male strata. Thus the power to detect differences between the 
subgroups and sex strata might not have been sufficient. Also, correlations between the 
selected pulmonary parameters and explanatory variables might have been weakened and in 
some cases falsely negative due to a small sample size. In retrospect, it would have been 
preferable to calculate sample size requirements according to sufficiently large non-
symptomatic observations within age and sex specific cells, over expected frequencies of 
COPD, which was the case in the present study. During analysis, adjustments due to complex 
sampling were made, and all study subjects were given a sampling weight calculated by 
adding the inclusion probabilities at each of the three selection stages. This reduced the 
precision of the confidence intervals computed. However, difficulties in obtaining a correct 
sampling frame prior to the selection, and thus ensuring selection probabilities proportionate 
to size at the different stages, may limit the extent to which the study results can be 
generalised. It would have been preferable to ensure a self weighted sample prior to the 
selection, which also would not violate the rule of selection proportionate to size.  
Due to time and capacity restraints, the two last clusters were not visited. This could also have 
implications on the generalisability of the study outcomes and increase the overall sampling 
error.  
 
Test procedures  
Spirometry 
One of the strengths of the present study is that the spirometry was carried out by use of a 
high- quality test device, and that strict adherence to ATS/ERS acceptability criteria were 
followed when assessing the manoeuvres. All study subjects performed a minimum of three 
and a maximum of eight tests, and the best FEV1, FEV6 and PEF were selected and used in 
further analysis. The spirometric testing was performed by trained assistants following a 
standardized procedure adherent to ATS/ERS guidelines (4, 5, 31). All spirograms were 
reviewed by an experienced chest physician, where ATS acceptability and reproducibility 
criteria were followed for selection of best pulmonary function curve; forced exhalation time 
should exceed a minimum of 6 seconds or show a plateau of the volume-time graph. Further 
each participant should display at least two acceptable reproducible maneuvers with both 
FEV1 and FEV6 within 200 ml and with absence of cough during the first second of the 
maneuvers (31). 
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Anthropometric data 
As the testing was conducted out-door in the field, the test devices were carried from house to 
house, and robust equipment, suitable for this setting was used. This might have influenced on 
the accuracy of the data obtained. Though difficult to carry through in the present study, it 
would have been preferable to have a stationary test lab, where adherence to gold standards 
within test procedures and equipment is made easier as the testing is less prone to 
environmental influences. Also, the anthropometric test equipment would not have been 
selected at the expense of being robust and easy to transport.  
However, training and supervision of field assistants and use of a standardized test procedure 
throughout the data collection have been ensured, to reduce the influence of measurement 
errors.   
 
Questionnaires 
The feasibility of the ATS-DLD questionnaire to obtain information regarding respiratory 
symptoms in this population must be considered, where both meaning and phrasing of words 
and illnesses are rooted in a different cultural context and might not capture the true picture of 
the study participants interviewed. The process of translating and back translating of the 
questionnaire was conducted with the purpose of reducing such measurements errors. 
However, developing culture specific questionnaires assessing respiratory symptoms and 
illness should be prioritised in future research.  
Also, the possible presence of response bias must be considered. As the questionnaires were 
both elaborate and time consuming, the bias known as satisficing, and the way the 
respondents are administrating the questionnaire, might reduce the validity of the recorded 
data. However, as the questionnaires were administered face to face by research assistants, 
there is an immediate opportunity to clear up misconceptions on the part of the respondent 
and this might reduce the risk of invalid responses.  
 
Discussion of findings 
The following pulmonary parameters were measured in all study participants; peak expiratory 
flow (PEF), forced expiratory volume in one second (FEV1), forced expiratory volume in six 
seconds (FEV6) and the FEV1/FEV6 ratio. In the present study FEV6 was chosen over FVC, 
as it has been shown to be less demanding for both the participant as well as the technician, as 
 25
it requires less exhalation time. It has also been demonstrated to display less test variability 
when compared to FVC (14, 15, 16).  
After evaluating the spirometric measurements, 39 study participants (10,7 %) did not 
accomplish tests results in compliance to ATS criteria, and were excluded from analysis 
regarding spirometric lung indices.                             
 
We have generated prediction equations for the following pulmonary parameters; FEV1, 
FEV6, FEV1/FEV6 and PEF from a non-symptomatic subsample of the study participants. 
Due to increased risk of false-positive diagnosis in the interpretation, it is recommended not 
to include too many indices of lung function in the testing, and the selected spirometric 
parameters are frequently used in assessment of respiratory diseases (1, 4, 5, 31). FEV1 is also 
shown to be an independent predictor of mortality from respiratory diseases (2, 4, 3, 5). In our 
study, we chose predicted values of FEV6 over FVC, both for its advantages in 
epidemiological fieldwork, and that it has shown to be an acceptable surrogate for FVC in 
diagnosing airflow obstruction (14, 15, 16). However, this makes a direct comparison to 
previously published reference values of FVC not applicable. We also derived prediction 
values of PEF from the study participants. Peak flow meters are relatively inexpensive 
compared to spirometric devices, and can be a more feasible investment for health services in 
low-income countries, yet produce useful information in clinical assessment of pulmonary 
illnesses, providing appropriate reference values are applied. 
 
Frequencies and proportions of respiratory symptoms and conditions are calculated and listed 
in table 2 and 3 in paper 2, based on the participants’ responses to the ATS-DLD respiratory 
questionnaire. Both presence of symptoms and illnesses were more frequently reported among 
the female participants, though considerable in both sexes. However, one must question the 
validity of answers regarding presence of respiratory illnesses as emphysema, which requires 
diagnostic tools as x-ray or whole body pletysmography to verify. Also, presence of asthma 
should be determined based on spirometric testing. Thus, reporting of prevalence of 
emphysema (1,9 % and 1,0 % in men and women respectively), and cases of asthma 
(recorded in 10,7 % of men and 10,2 % of women) should be interpreted with caution as it 
might not reflect the true picture in the population. There are no previous studies on 
respiratory symptoms in the general population from Sub-Saharan Africa, but in Mokoetle’s 
respiratory survey of a workforce in Johannesburg, the presence of respiratory symptoms 
among the study participants were also considerable and of similar magnitude (20). 
 26
 
Prevalence of COPD when applying a fixed cut off ratio of FEV1/FEV6 < 0,73, was 12,6 %, 
and it was equally distributed among men (13,9 %) and women (11,5 %). Prevalence of 
COPD when classified as below the lower limit of normal was 7,9 %, also equally distributed 
with 6,9 % and 8,7 % of men and women respectively. The latter method pays attention to the 
relation between age and lung volumes, and the bias of over-diagnosing COPD in the elderly 
and vice versa among younger adults is reduced, which may explain the lower prevalence 
calculated (3, 34). A limitation of our study is that COPD is diagnosed on basis of simple 
spirometry, though responses to a post-bronchodilator spirometric test and assessment of 
reversibility of airway obstruction are considered a necessity in diagnosing COPD (1, 2). 
However, due to limited resources and the nature of the data collection, it was not feasible to 
include post bronchodilator spirometry as part of the testing. Besides increased costs, 
transportation and storage demands, this would also imply a more elaborate training of 
assistants as well as a more time-consuming test procedure for the study participants.  
In any case, one can question whether the prevalence of COPD in our study consists of truly 
positive COPD cases, as the diagnostic method used fails to discriminate between subjects 
who are responsive and non responsive to a bronchodilator and thus possibly insufficient in 
differentiating COPD from asthma. According to a Norwegian study by Lehmann et al, a 
reversibility response of FEV1 increase ≥ 12 % and ≥ 200 ml after administration of a 
bronchodilator, was found in 2 % and 4 % of middle-aged (47-48 years) and elderly (71-73 
years) participants respectively (35). Thus only a small fraction of the study population had a 
clinical relevant bronchodilatation after inhalation of salbutamol. This indicates that the 
proportion of possibly false positive COPD cases in our study might not be considerable. 
However, Lehmann did not investigate the reversibility response among those of younger age. 
In any case, the subjects classified as having COPD in our study, had a clear obstructive 
ventilatory pattern, and all of the subjects were in their habitual condition at the time of 
testing, which we consider relevant for the diagnosing, despite the lack of a post-
bronchodilator test. GOLD acknowledges in its report that epidemiological field studies face 
challenges in quantifying prevalence and assessing diagnosis and severity of COPD, and 
emphasizes that in areas lacking access to state-of-the-art diagnostic tools, diagnosis should 
be made with the equipment available (16). This helps justify the diagnostic approach used in 
the present study. Prevalence of stage I and II COPD was 6,1 % and 5,8 % respectively. 
                                                 
6
 GOLD report, page 89 
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Among the study participants with COPD, only a small fraction were classified in stage 3 or 
higher (0,3 %). 
 
Conclusions 
• The following pulmonary parameters have been measured in all study participants: 
peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), forced 
expiratory volume in six seconds (FEV6) and the FEV1/FEV6 ratio.  
• We have generated prediction equations for the following pulmonary parameters: 
FEV1, FEV6, FEV1/FEV6 and PEF from a non-symptomatic subsample of the study 
participants.  
• Frequencies and proportions of respiratory symptoms among the study participants 
have been assessed based on responses to the ATS-DLD respiratory questionnaire.  
• Prevalence of COPD when applying a fixed cut off ratio of FEV1/FEV6 < 0,73, was 
12,6 %, and it was equally distributed among men (13,9 %) and women (11,5 %). 
Prevalence of COPD when classified as below the lower limit of normal was 7,9 %, 
also equally distributed with 6,9 % and 8,7 % of men and women respectively. 
Prevalence of stage I and II COPD was 6,1 % and 5,8 % respectively. Among the 
study participants with COPD, only a small fraction were classified in stage III or 
higher (0,3 %). 
 
Recommendations 
• The differences in predicted lung volumes derived from our study compared to values 
obtained by using previously published equations, emphasise the importance of using 
appropriate reference values in clinical assessment of respiratory illness, based on the 
same population as those being tested. However, in a longitudinal perspective, our 
predictions face limitations as they can only be considered reference values of today. 
Prediction equations should be updated at regular intervals, preferably every decade 
(4, 5). 
• Increased awareness, and more attention to causal relations of COPD are important 
steps towards developing strategies for both prevention and treatment of COPD in 
accordance with the local epidemiological context, and should be prioritized in future 
research. 
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• The prevalence of current smoking among the participants in our study must be 
considered disturbingly high among men (30 %). This should be given more attention 
in future research, as it has important implications concerning the health status and the 
expatiation of non-communicable diseases in the population in Dar Es salaam, 
Tanzania.  
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Introduction 
 
Availability of appropriate reference values is a necessity for interpretation of pulmonary 
function tests and in assessment of lung function and respiratory diseases. According to 
American Thoracic Society (ATS) recommendations, such reference values should be based 
on healthy people with the same anthropometric characteristics and ethnic origin as the 
subjects being tested (1). Nevertheless, many low–income countries are faced with scarce 
documentation regarding national prediction equations and must rely on foreign reference 
values adjusted with estimated ethnic correction factors (2, 3, 4, 5). The use of ethnic 
adjustment factors assumes that the relationship between spirometry outcome and sex, age, 
and anthropometric predictors are the same for the local population as for the foreign 
reference population.  This assumption is rarely well founded. Also, this method does not 
account for secular changes nor addresses underlying causes of ethnic differences in lung 
function, implicates artificially low ethnic standards, and may possibly result in a high false 
negative rate and missed diagnosis of respiratory diseases (2, 3, 4, 5).  
The present study aims to derive reference values from a healthy adult suburban population in 
Dar Es Salaam, Tanzania. This paper presents prediction equations generated from a non-
symptomatic subsample of the subjects being tested, and compares these equations to already 
published reference values. Both sitting and standing height have been measured and included 
as part of presumptive determinants of lung function, to allow for comparison of study results 
across countries and ethnicity (1, 2, 3, 5, 6, 7). 
 
Methods 
Study design and participants 
The study is based on a descriptive cross-sectional design. The source population comprised 
all adults above the age of 15 in Kinondoni district, a suburban area of Dar Es Salaam, 
Tanzania, roughly estimated to hold a population of 350,000.  Exact population registries do 
not exist. Participants were recruited by multistage cluster random sampling. In the first stage, 
two of the 27 wards of Kinondoni district were selected. At next stage, two areas in each ward 
were chosen. Each ward consisted of five areas. In the last stage, four ten-cell leaders were 
selected from each area, conducing to a total of 16 clusters. The term ‘Ten-cell leader’ refers 
to the smallest administrative unit in Tanzania, and one ten-cell leader has the responsibility 
for approximately 10-12 households (8). The number of ten-cell leaders varied in the selected 
areas; one area constituted a total of 40 ten-cell leaders, another consisted of 10 ten-cell 
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leaders and two areas had 8 ten-cell leaders. The primary sampling unit comprised all 
households under the selected ten-cell leaders.  
Another primary objective for the study,dealt with in a parallel paper, was to determine the 
prevalence of chronic obstructive pulmonary disease (COPD) in Tanzania. As such, the 
sample size was calculated at a 95 % confidence level, and with precision set at 0.05, and 
assumptions of expected frequency of COPD were based on a study from South Africa, 
showing a prevalence of COPD around 12 % (9). Estimating prevalence of COPD to 15% and 
accounting for reduced precision due to cluster sampling through use of a design effect at 1.5, 
the minimum sample size required was calculated to 300 participants. Recruiting study 
subjects was accomplished by informing the randomly selected ten-cell leaders about the aim 
of the study, seeking their approval to collect the necessary data. Next, a mobile testing team 
carried out a knock-on-door approach to the households under their selected ten-cell leaders. 
Subjects within the age-span examined and who were willing to participate, were included in 
the study. Selection of subjects eligible for generating reference values followed ATS 
recommendations, where subjects with negative responses to core questions from ATS-DLD 
regarding respiratory symptoms and doctor diagnosed heart/chest illnesses were selected, 
providing their spirometric data met ATS criteria (6, 10). Questions regarding self reported 
occupational exposures were excluded from the stratification because they yielded unreliable 
information. However, duration of symptoms like cough, phlegm, wheezing and 
breathlessness were accounted for, as were past or present history of smoking and respiratory 
illnesses like chronic bronchitis, emphysema, asthma, tuberculosis, doctor diagnosed heart 
problem and high blood pressure confirmed by a doctor. 
 
Data collection methods: definitions and measurement 
Spirometry  
Spirometry was performed using the ndd EasyOne spirometer (ndd Medizintechnik AG), 
which has proven to be suitable in field work as it operates on batteries and requires no 
calibration while achieving a high degree of accuracy and reliability (11). The following 
parameters were measured; peak expiratory flow (PEF), forced expiratory volume in one 
second (FEV1), and forced expiratory volume in six seconds (FEV6). In the present study 
FEV6 was chosen over FVC, as it has been shown to be advantageous due to less exhalation 
time, implying both shorter coaching time as well as reduced physical discomfort for the 
participants. It has also been demonstrated to display less test variability when compared to 
FVC (11, 12). All study subjects performed a minimum of three and a maximum of eight 
 35
tests, and the best FEV1, FEV6 and PEF were selected and used in further analysis. The 
spirometric testing was performed by trained assistants following a standardized procedure 
adherent to ATS/ERS guidelines (6, 10). The test subjects performed spirometry without nose 
clips, and sitting position was allowed if participants found the maneuver in standing position 
to be exhausting. All spirograms were reviewed by an experienced chest physician, where 
ATS acceptability and reproducibility criteria were followed for selection of best pulmonary 
function curve; forced exhalation time should exceed a minimum of 6 seconds or show a 
plateau of the volume-time graph. Further, each participant should display at least two 
acceptable reproducible maneuvers with both FEV1 and FEV6 within 200 ml and with 
absence of cough during the first second of the maneuvers (10).  
 
Anthropometry 
Anthropometric data, including weight, standing height and sitting height were obtained using 
robust equipment easy to transport in the field. The anthropometric measurements were 
collected by field personnel trained by the author, and the standardized procedure was 
monitored by the principal investigator throughout the data collection.   
The participants’ weights were obtained using a weight scale. Standing height was measured 
using a metal tape-measure and with heels, shoulders and occiput positioned against the tape. 
Sitting height was measured with a tape-measure affixed to a vertical wooden plank with the 
subjects sitting on a firm wooden chair with buttock, shoulder-blades and occiput touching the 
plank. Participants performed the anthropometric measuring barefoot. 
Age was recorded as birth-date or as mid year in the year of birth. The data were transformed 
to age in years in further analysis. 
 
Questionnaire data 
Respiratory symptoms were recorded using the ATS-DLD validated questionnaire, which was 
translated into Swahili, then back-translated to English prior to data collection, to ensure that 
questions and the phrasing used were adherent to the original format.  
Questions regarding socioeconomic status were derived from a culture specific questionnaire 
used in the Tanzania Demographic Health Survey from 1999 and 2002. The questionnaire 
was administered face-to-face by field personnel, trained to reduce information bias regarding 
interview technique, where phrasing of questions, and appropriate wording, was enhanced to 
obtain acceptable intra and inter- observer variability. 
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Ethical considerations 
Approval was obtained from the Ethical Committee of Western Norway (REK-Vest) and the 
Medical Research Coordinating Committee of the National Institute for Medical Research 
(MRCC). After subjects eligible for participation were informed of the nature and purpose of 
the study, and had given their informed consent, they were enrolled providing inclusion 
criteria were met. If disease that needed medical attention was found in any study participant, 
the person was aided with a referral to proper medical care.  
 
Statistical analysis 
Data were analyzed using standardized and hierarchical multiple regression techniques. Both 
linear and curvilinear formulae were obtained, and the model best fitted for the present data 
were chosen. The following dependent variables were applied; FEV1, FEV6, PEF and 
FEV1/FEV6, and regressed against the following independent variables; age, height and 
weight. The explanatory variables were assessed in terms of highest contributing R statistic, 
variable significance at p<0.05, partial correlation coefficients and lowest SEE values. 
Outliers were defined as cases that had standardized residual values above 3,0 or below -3,0, 
and were excluded from further analyses. Preliminary analyses were conducted to ensure no 
violation of the assumption of normality, linearity and multicollinearity. Prediction equations 
were estimated separately for men and women. The lower limit of normal (LLN) was defined 
as the 5th percentile, estimated as 1,645 × SEE, for each of the dependent variables. The 
FEV1/FEV6 ratio did not perfectly match a Gaussian distribution, and logarithm and square 
root transformation were conducted to assess whether the proportion of skewness decreased. 
As the distribution still showed some deviation from the normal curve and the standard error 
of estimate was nearly identical to the non log transformed, the non log transformed 
FEV1/FEV6 was selected in further analyses. 
Reference values generated from the present study were compared to previously published 
predictions by use of paired t-tests, and the magnitude of mean differences was obtained by 
Eta squared calculations. The Independent-Sample T-test was used to compare continuous 
variables, and Pearson Chi square and Wald statistic tests were used to compare group 
differences for categorical variables. Descriptive statistics are reported as means and standard 
deviations (SD) when normally distributed, skewed data are expressed in medians and 
percentiles. Calculations were done using the Statistical Package for the Social Sciences 
version 15 (SPSS Inc., Chicago, IL, USA). 
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Questionnaire data were double entered, cleaned and coded using Epi data version 3.1 (Centre 
for Disease Control and Prevention, Atlanta, GA, USA), and were exported to SPSS for the 
statistical analyses. The spirometric data were automatically stored in the spirometres used, 
and were electronically exported to SPSS. 
 
Results 
Of the 16 selected clusters, 14 were visited, and a total of 365 subjects were enrolled in the 
study, 159 (43,6 %) men and 206 (56,4 %) women. As 135 subjects in the visited households 
were absent at the time of testing, the response rate attained was 74%. However, the 
denominator in this fraction included subjects with unknown eligibility status. Further, 41 
participants were excluded from the study due to conditions contraindicating spirometry 
testing (10): 19 were due to known heart disorder, 15 had undergone chest/abdominal surgery, 
5 were in last trimester of pregnancy, and 2 had undergone eye surgery. Eleven eligible 
subjects refused to participate, giving a cooperation rate of 97 %. After evaluating the 
spirometric measurements, 39 study participants (10,7 %) did not accomplish tests results in 
compliance to ATS criteria, and were excluded from analysis regarding spirometric lung 
indices.                             
On the basis of the selection criteria, a total of 150 subjects, 52 men (32,7 %) and 98 women 
(47,6 %) were selected to the reference value group. Median age for the selected men and 
women were 34 years. Tables 1 and 2 summarize socio-demographic characteristics in the 
reference sample; table 1 presents the age distribution and descriptive statistics regarding 
anthropometry and spirometry parameters, whereas table 2 gives a summary of occupations.  
Prior to the regression modeling, bivariate analyses were conducted to evaluate correlations 
for FEV1, FEV6, FEV1/FEV6 and PEF according to sample mean age, height and weight. 
This is summarized in table 3. Age, height and sitting height correlated significantly with the 
dependent variables FEV1 and FEV6 for both sexes. For women this was also the case with 
PEF. FEV1/FEV6 showed no significant correlation with height, and neither of the dependent 
variables correlated with weight in the female strata, whereas for men, weight showed a 
correlation with the FEV1/FEV6 ratio. 
Further, group differences for categorical variables regarding exposure to occupational 
pollutants and other socioeconomic conditions were investigated in relation to the above 
mentioned pulmonary parameters. Based on these preliminary analyses, no significant group 
differences could be traced, and they were not taken into further consideration in the 
regression analysis. 
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The regression analyses were performed separately for males and females. The exponential 
variable height square was entered into the equation together with the age, height and weight, 
to assess whether a linear or curvilinear model produced best fit for the present data. In the 
male strata, an exponential model was selected as regression equation, as height square 
explained an additional 3,2 % and 3,6 % of the variance in FEV1 and FEV6 respectively, and 
contributed 1,8 % to the total R square for PEF. For FEV1 and FEV6, R statistics increased 
from 0,462 to 0,494 (p = 0,09) and from 0,445 to 0,481 (p = 0,08) respectively, when the 
effect of the other independent variables had been statistically controlled for. For PEF, R 
square change was more modest, increasing from 0,223 to 0,241 (p = 0,3), after controlling 
for age and height , but was retained in the final model. When assessing the model fit for men 
using sitting height as explanatory variable, a curvilinear formulae was also considered most 
suitable for predicting FEV1 and FEV6 where sitting height square explained an additional 
3,1 % and 3,5 % of the variance in these variables and R square values changed from 0,419 – 
0,450 (p = 0,1) and from 0,473 to 0,508 ( p = 0,07) respectively. For the dependent variable 
PEF, a linear model was applied, as the exponential variable did not contribute much to the 
total R square (0,4 %) or for the R square values (0,271 – 0,274, p = 0,6). For women, the 
exponential variable height square, explained an additional 2,0 % of the total variance in PEF, 
with R statistics increasing from 0,219 – 0,239 (p = 0,1). Similarly, sitting height square, 
contributed 1,9 % to the total R square change for PEF, with R square increasing from 0,237 – 
0,256 (p = 0,1), and a curvilinear model were selected as equation. For the dependent 
variables FEV1 and FEV6, a linear model was chosen in further analysis, as neither of the 
exponential variables height square or sitting height square contributed to the total R square. 
Weight turned out non-significant in the male strata, and showed only a minor contribution to 
the variability of the regression models, and was excluded from the formulas. For women 
weight had a part correlation coefficient of 0,178, when regressed against PEF, explaining an 
additional 3,17 % of the total R square (p = 0,05), and was retained in the final model when 
standing height was part of the independent variables. For the dependent variables FEV1, 
FEV6 and FEV1/FEV6, weight was non-significant, and was removed from the equations in 
further analyses. Height, and height square in the exponential equations for men and women, 
entered all the regression models with the exception of the model predicting FEV1/FEV6, as 
it did not provide a significant contribution to the variance in the present sample and only 
showed a marginally improvement of the R statistics and the corresponding SEE values. 
Tables 4 and 5 summarize the prediction equations generated. All the spirometric parameters 
were negatively related to age, and all increased with height, with exception of FEV1/FEV6. 
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The lower limit of normal (LLN) is presented as – 1,645 x SEE which is the age and height 
specific, estimated 5th percentile for the reference sample. 
The prediction equations derived from our sample are compared to those of Mokoetle, 
reference values generated from a healthy South African University workforce (7), and with 
Hankinson’s equation (NHANES iii),of African-American above 20 years of  age (13). 
Reference values for the male strata are also compared to Louw’s equations of Black and 
White South African men and to the predictions of Mustafa of Northern Sudanese but also 
tested to fit Tanzanian men (5, 14). As Mustafa’s predictions were generated in 1977, they are 
considered old. However, they are included in the comparison of published equations to 
assess for secular changes in predicted lung volumes. Figure 1-4 present scatter plots of 
predicted FEV1 for men and women applying the equations of Mokoetle, Hankinson and 
Louw. Table 6 summarizes mean difference of FEV1 values between our prediction equations 
to those in comparison. 
 
Discussion 
We have generated prediction equations for the following pulmonary parameters; FEV1, 
FEV6, FEV1/FEV6 and PEF from a non-symptomatic subsample of the study participants. In 
accordance with GOLD and ATS guidelines the selected lung function indices are frequently 
used in pulmonary testing and in assessment of respiratory diseases (1, 10). When applying 
Mokoetle’s and Louw’s predictive equations of Black South African men to our male strata, 
this generated larger values of FEV1 compared to those derived from our study, thus 
overestimating normal values of FEV1 in the present sample population. This was also 
evident when using Hankinson’s equation of African-American adults above 20 years of age, 
though the mean difference to our predictive equations was smaller. Louw’s reference values 
of White South African men, showed an even larger mean difference in FEV1 at 1,2 litre 
when compared to the present study values. Applying equations using sitting height as a 
proxy estimate of height reduced this difference to 1,0 litre. This is in accordance with 
previous publications, were ethnic differences in lung volumes is thought to be partly due to 
difference in body build and that Blacks have smaller trunk-to-leg ratio than Whites (10). An 
adjustment using sitting height as an anthropometric measure in lung function testing reduces 
these ethnic differences (1, 2, 3, 5, 10). The predicted FEV1 values for the women in our 
study were also significantly lower compared to those of Mokoetle and Hankinson, with a 
mean difference of 0,30 and 0,23 litres respectively. Louw did not generate reference values 
for women in his study. A factor that might have contributed to the differences in predicted 
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FEV1 values, is the study population used for generation of reference values. Both Mokoetle 
and Louw used occupation based samples in their studies, which have proven to generate 
higher lung volumes than studies deriving reference values from a community source, which 
was the case in the present study (4). This bias, known as the healthy-worker effect, might 
explain some of the variation in mean FEV1 values, but also possible differences in socio-
environmental conditions for the study populations generating the reference values must be 
considered, since it have been thought to influence lung function (2, 3, 5, 10, 11, 15). In 
addition, the altitude in Johannesburg is 2000 m above sea level, which can account for up to 
400 ml according to the study of White et al, published in 1994 (4). Also, methodological 
differences between the studies, like the equipment used for spirometric testing and variations 
in cut-off criteria for acceptability assessment, might play a role in deriving different 
predicted values. Such possible biases in the process of generating reference values emphasise 
the importance of using appropriate prediction equations to prevent a possible risk of under-
diagnosing or over-diagnosing respiratory illnesses and disease severity. When comparing our 
equations to those of Mustafa in 1977, this generated almost similar predicted values for 
FEV1 (14). The Sudanese site was situated at 400 m altitude, and the sample was derived 
from an urban community source. This raise questions to what extent secular changes, and the 
bias known as the cohort effect influence on the spirometric measurements, though possible 
differences in socio-environmental conditions for the study populations generating the 
reference values has been thought to influence lung function. On the other hand, the present 
sample size might not been sufficiently large to detect differences in lung volumes according 
to changes in determinants as nutrition, health status and environmental factors. The study 
also failed to point out any interconnectedness between lung volumes and socioeconomic 
factors.   
In our study, we have chosen predicted values of FEV6 over FVC, both for its advantages in 
epidemiological fieldwork, and that it has been shown to be an acceptable surrogate for FVC 
in diagnosing airflow obstruction (16, 17). However, this makes a direct comparison to 
previously published reference values of FVC not applicable.  
We also derived prediction values of PEF from the study participants. Peak flow meters are 
relatively inexpensive compared to spirometric devices, and can be a more feasible 
investment for health services in low-income countries, yet produce useful information in 
clinical assessment of pulmonary illnesses, providing appropriate reference values are 
applied. 
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One of the strengths of the present study is that the spirometric testing was carried out by use 
of high- quality apparatus in a realistic “in-the-field” setting, and that strict adherence to 
ATS/ERS acceptability criteria was followed when assessing the manoeuvres. As the testing 
was conducted out-door in the field, the test devices were carried from house to house, and 
robust anthropometric measures, suitable for this setting were used. This might have 
influenced on the accuracy of the anthropometric data obtained. However, training and 
supervision of field assistants and use of a standardized test procedure throughout the data 
collection have been ensured, to reduce the influence of measurement errors.  
The feasibility of the ATS-DLD questionnaire to obtain information regarding respiratory 
symptoms in this population must be considered, where both meaning and phrasing of words 
and illnesses are rooted in a different cultural context and might not capture the true picture of 
the study participants interviewed. Developing culture specific questionnaires assessing 
respiratory symptoms and illness should be prioritised in future research.   
Some limitations of the present study need to be considered. The study sample was selected 
randomly, through a multistage cluster technique. However, difficulties in obtaining a correct 
sampling frame prior to the selection, and thus ensuring selection probabilities proportionate 
to size at the different stages, may limit the extent to which the study results can be 
generalised. Due to time and capacity restraints, the two last clusters were not visited. This 
also have implications on the generalisability of the study outcomes and increase the overall 
sampling error. The available sample in the non-symptomatic group was small, particularly in 
the male strata. Thus the power to detect differences between the subgroups and sex strata 
might not have been sufficient.  Also, correlations between the selected pulmonary parameters 
and explanatory variables might have been weakened and in some cases falsely negative due 
to a small sample size. In retrospect, it would have been preferable to calculate sample size 
requirements according to sufficiently large non-symptomatic observations within age and sex 
specific cells, over expected frequencies of COPD, which was the case in the present study. 
However, the study results still present valuable information. The differences in predicted 
lung volumes derived from our study compared to values obtained by using previously 
published equations, emphasise the importance of using appropriate reference values in 
clinical assessment of respiratory illness, based on the same population as those being tested. 
Measurement of lung function in the proposed catchment area and age group is also 
important, as there is no recent published data on respiratory function in the general 
population in Dar Es Salaam, Tanzania.  
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Table 1  
 
 
 
 
 
 
 
Table 2  
Table 2; distribution of job categories reference sample 
Occupation*, N (%) Men (n = 41) Women (n = 66) 
White-collar worker/professional 7   (13,5) 5   (5,1) 
Agriculture 12 (23,1) 23 (23,5) 
Blue-collar worker 13 (25,0) 4   (4,1) 
Sales/shopkeeping 5   (9,6) 15 (15,3) 
Student 4   (7,7) 7   (7,1) 
Housewife/housegirl  12 (12,2) 
N = number of responders, % = proportion of responders 
* Total missing rate of 28,7 % when listing occupation   
 
 
 
 
Table 1; age distribution and descriptive statistics reference sample 
 Men (n = 52) Women (n = 98) 
Age categories, no (%) 
< 20 
 
7   (13,5)                 
 
12 (12,2) 
20-29 16 (30,8) 34 (34,7) 
30-39 11 (21,2) 25 (25,5) 
40-49 10 (19,2) 13 (13,3) 
50-59 4   (7,7) 10 (10,2) 
60-69 3   (5,8) 3   (3,1) 
70+ 1   (1,9) 1   (1,0) 
Height, mean ± SD, cm 166,38  ± 7,86 157,16 ± 5,96 
Sitting height mean ± SD, cm 81,45 ± 3,61 78,08  ± 3,42 
Weight, mean ± SD, kg 65,58 ± 11,50 61,48 ± 14,99 
FEV1, mean ± SD, L 3,02± 0,65 2,24 ± 0,51 
FEV6, mean ± SD, L 3,59 ± 0,68 2,71 ± 0,56 
FEV1/FEV6, mean ± SD 0,840 ± 0,079 0,825 ± 0,070 
PEF, mean ± SD, L 7,98 ± 2,32 5,48 ± 1,38 
N = number of responders, % = proportion of responders, SD = standard deviation 
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Table 3 
Table, bivariate correlation 
Men (n = 52) 
 
    Age, years 
    Height, cm 
    Sitting height, cm 
    Weight, kg 
 
Women (n = 98) 
 
    Age, years 
    Height, cm 
    Sitting height, cm 
    Weight, kg 
 
FEV1, L 
 
-0,461** 
0,536** 
0,475** 
-0,007 
 
 
 
-0,738** 
0,405** 
0,383** 
0,142 
FEV6, L 
 
-0,333* 
0,603** 
0,621** 
0,136 
 
 
 
-0,628** 
0,467** 
0,426** 
0,153 
FEV1/FEV6 
 
-0,415* 
 0,026 
-0,109 
-0,294* 
 
 
 
-0,557** 
-0,044 
-0,008 
0,009 
PEF, L 
 
-0,205 
0,416** 
0,482** 
0,202 
 
 
 
-0,397** 
0,258* 
0,314** 
0,195 
** correlation is significant at the 0,01 level (2-tailed) 
* correlation is significant at the 0,05 level (2-tailed)  
 
 
 
Table 4 
 
Table 4; prediction equations reference sample 
Model                                                                                                                R²         SEE         5th percentile 
Men 
    FEV1 = 33,173 – 0,0203 × A – 0,394 × H + 0,00130 × H²                         0,491    0,477        0,785 
    FEV6 = 37,052 – 0,0149 × A – 0,444 × H + 0,00148 × H²                         0,479    0,503        0,827 
    PEF = 94,661 – 0,0314 × A – 1,143 × H + 0,00377 × H²                            0,222    2,108        3,468 
    FEV1/FEV6 = 0,920 – 0,00231 × A                                                            0,172     0,073       0,120 
Women 
    FEV1 = – 1,133 – 0,0261 × A + 0,0270 × H                                                0,658    0,317       0,521 
    FEV6 = – 2,031 – 0,0288 × A + 0,0350 × H                                                0,553    0,385       0,633 
    PEF = 104,066 – 0,0386 × A – 1,286 × H + 0,00419 × H² + 0,0179 × W   0,239    1,229       2,022 
    FEV1/FEV6 = 0,920 – 0,00282 × A                                                             0,310    0,058       0,095                     
A = age in years, H = height (cm), H² = height square, W = weight 
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Table 5  
 
Table 5; prediction equations using sitting height reference sample 
Model                                                                                                R²         SEE           5th percentile 
Men 
    FEV1 = 29,530 – 0,0222 × A – 0,713 × SH + 0,00486 × SH²     0,446    0,498         0,819  
    FEV6 = 30,233 – 0,0168 × A – 0,753 × SH + 0,00531 × SH²     0,508    0,489         0,804 
    PEF = – 15,682 – 0,0289 × A + 0,303 × SH                                0,264    2,030         3,339 
Women 
    FEV1 = – 0,0196 – 0,0253 × A + 0,0398 × SH                           0,614     0,319         0,525 
    FEV6 = – 0,762 – 0,0232 × A + 0,0544 × SH                             0,502     0,401         0,660 
    PEF = 51,653 – 0,0359 × A – 1,267 × SH + 0,00883 × SH²       0,236     1,225         2,015                       
A, age in years; SH, sitting height (cm); SH², sitting height square 
 
 
 
 
Table 6 
 
Table 6; Mean difference in FEV1 values; Our predictive compared to Mokoetle, Louw and Hankinson. 
Mean difference in FEV1 to Our predictions (95 % CI) 
                                                          Men (n = 52)                            Women (n =98) 
Mokoetle predicitive Black S Afr    0,45  (0,38 - 0,53)                      0,30      (0,28 - 0,31) 
Louw predictive Black S Afr           0,72  (0,66 - 0,78)             
Louw predictive White S Afr           1,2   (1,17 – 1,33) 
Hankinson predictive Afr Am          0,22 (0,19 - 0,25)                      0,23       (0,21 - 0,25)    
Mustafa predictive Sudanese           0,063 (0,046 – 0,080)                                                                                    
 
 
 
 
 
 
 47
Figure 1: Scatter plot of predicitive FEV1 values of male strata applying equations of 
Louw, Hankinson, Mokoetle and those generated in the present study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2; scatter plot of predictive FEV1 values of male strata applying equations of 
Louw, Mokoetle and those generated in the present study. Use of sitting height in 
equations 
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Figure 3; scatter plot of predictive FEV1 values in female strata applying equations of 
Mokoetle, Hankinson and those generated in the present study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4; scatter plot of predictive FEV1 values applying equations of Mokoetle and 
those in present study. Use of sitting height in equations 
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Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is by the WHO Global Burden of Disease 
Study projected to increase in magnitude and rank as third leading cause of death worldwide 
in 2020, an expansion brought forth by both an ongoing health transition characterizing many 
of today’s low and middle-income populations, as well as an anticipated increase in cigarette 
smoking in several African and Asian countries (1, 2). Studies concerning respiratory 
symptoms and prevalence of obstructive lung disease in low-income setting are yet rare. The 
expected frequency and burden of respiratory impairment is however anticipated to be 
considerable in these countries, both for the presence of potential hazards as occupational and 
domestic exposures, as for infections and morbidities, like tuberculosis and HIV, all 
influences known to be detrimental to respiratory health (2, 3, 4, 5). This reinforces the 
concept of COPD as both underreported and under-diagnosed in low-income countries, none 
the less likely causing high morbidity and mortality in poorly resourced populations, with less 
access to health care and preventive actions. 
This paper aims to estimate prevalence of respiratory symptoms from a random sample of the 
population. Further, prevalence of COPD will be determined based on spirometric values 
according to adjusted GOLD7 and ATS8/ERS9 diagnostic criteria (2, 6, 7, 8, 9). 
 
Methods 
Study design and participants 
The study is based on a descriptive cross-sectional design. The source population comprised 
all adults above the age of 15 in Kinondoni district, a suburban area of Dar Es Salaam, 
Tanzania, roughly estimated to hold a population of 350,000.  Exact population registries do 
not exist. Participants were recruited by multistage cluster random sampling. In the first stage, 
two of the 27 wards of Kinondoni district were selected. At next stage, two areas in each ward 
were chosen. Each ward consisted of five areas. In the last stage, four ten-cell leaders were 
selected from each area, adding up to a total of 16 clusters. The term ‘Ten-cell leader’ refers 
to the smallest administrative unit in Tanzania, and one ten-cell leader has the responsibility 
for approximately 10-12 households (10). The number of ten-cell leaders varied in the 
selected areas; one area constituted a total of 40 ten-cell leaders, another consisted of 10 ten-
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cell leaders and two areas had 8 ten-cell leaders. The primary sampling unit comprised all 
households under the selected ten-cell leaders. Sample size was calculated at a 95 % 
confidence level, and with precision set at 0.05. Assumptions of expected frequency of COPD 
were based on a study in South Africa, showing a prevalence of COPD around 12 % (11). 
Estimating prevalence of COPD to 15% and accounting for reduced precision due to cluster 
sampling through use of a design effect at 1.5, the minimum sample size required was 
calculated to 300 participants. Recruiting study subjects was accomplished by informing the 
randomly selected ten-cell leaders about the aim of the study, and seeking their approval to 
collect the necessary data. Next, a mobile testing team carried out a knock-on-door approach 
to the households under their selected ten-cell leaders. Subjects within the age-span examined 
and who were willing to participate, were included in the study. 
 
Data collection methods: definitions and measurement 
Spirometry  
Spirometry was performed using the ndd EasyOne spirometer (ndd Medizintechnik AG), 
which has proven to be suitable in field work as it operates on batteries and requires no 
calibration while achieving a high degree of accuracy and reliability (11). The following 
parameters were measured; peak expiratory flow (PEF), forced expiratory volume in one 
second (FEV1), and forced expiratory volume in six seconds (FEV6). In the present study 
FEV6 was chosen over FVC, as it has been shown to be advantageous due to less exhalation 
time, implying both shorter coaching time as well as reduced physical discomfort for the 
participants. It has also been demonstrated to display less test variability when compared to 
FVC (11, 12, 13, 14). All study subjects performed a minimum of three and a maximum of 
eight tests, and the best FEV1, FEV6 and PEF were selected and used in further analysis. The 
spirometric testing was performed by trained assistants following a standardized procedure 
adherent to ATS/ERS guidelines (6, 8). The test subjects performed spirometry without nose 
clips, and sitting position was allowed if participants found the maneuver in standing position 
to be exhausting. All spirograms were reviewed by an experienced chest physician, where 
ATS/ERS acceptability and reproducibility criteria were followed for selection of best 
pulmonary function curve; forced exhalation time should exceed a minimum of 6 seconds or 
show a plateau of the volume-time graph. Further each participant should display at least two 
acceptable reproducible maneuvers with both FEV1 and FEV6 within 200 ml and with 
absence of cough during the first second of the maneuvers (8).  
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Age was recorded as birth-date or as mid year in the year of birth. The data were transformed 
to age in years in further analysis. 
 
Questionnaire data 
Respiratory symptoms were recorded using the ATS-DLD10 validated questionnaire, which 
was translated into Swahili, then back-translated to English prior to data collection, to ensure 
that questions and the phrasing used were adherent to the original format.  
Questions regarding socioeconomic status were derived from a culture specific questionnaire 
used in the Tanzania Demographic Health Survey from 1999 and 2002. The questionnaire 
was administered face-to-face by field personnel, trained to reduce information bias regarding 
interview technique, where phrasing of questions, and appropriate wording, was enhanced to 
obtain acceptable intra and inter- observer variability. 
 
Ethical considerations 
Approval was obtained from the Ethical Committee of Western Norway (REK-Vest) and the 
Medical Research Coordinating Committee of the National Institute for Medical Research 
(MRCC). After subjects eligible for participation were informed of the nature and purpose of 
the study, and had given their informed consent, they were enrolled providing inclusion 
criteria were met. If disease that needed medical attention was found in any study participant, 
the person was aided with a referral to proper medical care.  
 
Statistical analysis  
Data regarding demography, respiratory symptoms and socio-environmental conditions 
included all responders. Estimation of COPD prevalence included study participants with 
acceptable spirometry only. Definition and classification of airway obstruction was based on, 
both adjusted GOLD criteria and ATS/ERS criteria (2, 3, 9, 12, 14). According to GOLD, 
COPD is determined by use of a fixed percentage of spirometric predicted values, with 
airflow limitation defined as an FEV1/FVC11 ratio less than 70 % (2, 3, 9). In our study we 
used an adjusted GOLD definition, as FEV6 was selected over FVC as spirometric parameter, 
and a FEV1/FEV6 ratio less than 73% was applied as cut off point (14). When applying 
ATS/ERS guidelines, ventilatory obstructivity is defined as a reduced FEV1/FEV6 ratio 
below the statistically derived fifth percentile of the predicted value, and we also used this 
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lower limit of normal as a cut off to determine proportion of responders with COPD (6, 7, 9). 
Disease severity was based on GOLD disease stages (2, 6, 7). Diagnoses were made on the 
basis of simple spirometry without any attempt at bronchodilation. Descriptive statistics were 
applied, using frequencies and cross tabulation. The Independent-Sample T-test was used to 
compare continuous variables, and Pearson Chi square and Wald statistic tests were used to 
compare group differences for categorical variables. Logistic regression analyses were carried 
out to assess and adjust for potential confounders for determinants of COPD. The models 
were adjusted for the following variables; sex, age, smoking status, pack years, presence of 
occupational and domestic exposures and level of socioeconomic position. The smoking 
exposure variable, pack years, was computed by dividing the number of cigarettes smoked per 
day by 20, multiplied by number of years smoked. Pack years were computed for both current 
and ex-smokers. Smoking status contained the following variables; never smoked, ex-smoker 
and current smoker. Occupational exposure was computed by the following variables; worked 
≥ 1 year in dusty work or ever exposed to gas/chemical in work. Domestic exposure was 
constructed by positive responses to question regarding use of biomass and charcoal at home. 
Measures regarding socioeconomic information were collected at individual level, and a 
socioeconomic position variable (SEP index) was constructed according to both economic and 
social dimensions represented by questions regarding level of education, present employment, 
recent work for pay and available money resources derived from the culture specific 
questionnaire used. 
 Logistic regression analyses were generated to estimate odds ratios (OR) with 95 % 
confidence intervals (CI) of COPD. Preliminary analyses were conducted to ensure no 
violation of the assumption of normality and multicollinearity. Both univariate and 
multivariate analyses were conducted. The models were assessed by goodness of fit tests. 
Prevalence estimates were adjusted for multistage cluster sampling during analyses. Each 
participant was given a sampling weight constructed by use of SPSS complex samples 
analysis, where inclusion probabilities at each of the three stages of the sampling procedure 
were added. Variables and differences were assessed in terms of significance at p< 0,05 level 
and their 95 % confidence intervals. Descriptive statistics are reported as means and standard 
deviations (SD) when normally distributed, skewed data are expressed in medians and 
percentiles. Calculations were done using the Statistical Package for the Social Sciences 
version 15 (SPSS Inc., Chicago, IL, USA). 
Questionnaire data were double entered, cleaned and coded using Epi data version 3.1 (Centre 
for Disease Control and Prevention, Atlanta, GA, USA), and were exported to SPSS for the 
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statistical analyses. The spirometric data were automatically stored in the spirometres used, 
and were electronically exported to SPSS. 
 
Results 
Of the 16 selected clusters, 14 were visited, and a total of 365 subjects were enrolled in the 
study, 159 (43,6 %) men and 206 (56,4 %) women. As 135 subjects in the visited households 
were absent at the time of testing, the response rate attained was 74%. However, the 
denominator in this fraction included subjects with unknown eligibility status. Further, 41 
participants were excluded from the study due to conditions contraindicating spirometry 
testing (8): 19 were due to known heart disorder, 15 had undergone chest/abdominal surgery, 
5 were in last trimester of pregnancy, and 2 had undergone eye surgery. Eleven eligible 
subjects refused to participate, giving a cooperation rate of 97 %. After evaluating the 
spirometric measurements, 39 study participants (10,7 %) did not accomplish tests results 
compliant with ATS criteria, and were excluded from analysis regarding spirometric lung 
indices. Median age was 37 and 34 years for the male and female strata respectively. Age 
ranged from 16-79 for men and 15-90 for women. Table 1 presents sociodemographic 
characteristics of the study participants, as age categories, job categories, level of education 
and proportion of subjects with low socioeconomic position defined from a set of constructed 
core variables from the socio environmental questionnaire.  
 
Tables 2 and 3 summarize frequencies and proportions of respiratory symptoms and 
conditions, based on the participants’ responses to the ATS-DLD questionnaire. Both 
presence of symptoms and illnesses were more frequently reported among the female 
participants, though considerable in both sexes, with 26,4 % of men and 35,0 % of women 
reporting that they usually cough. Similarly, usually phlegm was recorded in 25,2 % and   
32,0 % in men and women respectively. Also 22,0 % of the male strata, and 19,9 % of women 
responded that they have had problems with wheezing. Positive responses to questions 
regarding lung trouble before the age of 16, was recorded in 8,8 % in men and 12,6 % in 
women, and a total of 19,5 % and 17,5 % of men and women respectively, responded that 
they have had problems with chest illnesses during the past three years. 
 
In tables 4 and 5 exposures to various risk factors are reported; table 4 presents history and 
magnitude of current/previous smoking among study participants, and table 5 summarizes self 
judged exposure to occupational and domestic pollutants. Men reported more frequently 
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exposure of dust and gas/chemicals in work, whereas a higher proportion among women 
reported presence of domestic exposure as biogas and charcoal. A total of 14,0 % of the study 
population responded that they were current smokers, and 4,7 % was ex-smokers. However, 
patterns of cigarette smoking differed substantially between the sexes, where the proportion of 
current smokers was considerably higher for men (30,2 %) than for women (1,5 %). Also 8,8 
% of men, in contrast to only 1,5 % of women,  reported a previously history of smoking. 
Mean pack-years for current smokers were 8,7 and 6,6 years for men and women respectively, 
whereas mean pack-years for ex-smokers were 7,5 for men, and 1,47 for women.  
 
Prevalence of adjusted GOLD defined COPD when applying a fixed cut off ratio of 
FEV1/FEV6 < 0,73, was 12,6 %, and it was equally distributed among men (13,9 %) and 
women (11,5 %). Prevalence of ATS/ERS defined COPD when classified as below the lower 
limit of normal was 7,9 %, also equally distributed with 6,9 % and  8,7 % of men and women 
respectively. This is presented in table 6, together with frequency and proportion of cases of 
COPD according to GOLD’s four disease severity stages. Among the study participants with 
COPD, only a small fraction were classified in stage 3 or higher (0,3 %). Figures 1-4 presents 
scatter plots of FEV1/FEV6 values versus age in both sexes. The proportions of observations 
defined as COPD cases according to both a fixed FEV1/FEV6 ratio < 0.73 and below the 
LLN are marked. The age distribution of COPD cases according to GOLD and ATS/ERS are 
also summarized in table 7.  
 
Direct logistic regression was performed to assess the impact of certain determinants on 
COPD. Separate analyses were carried out for GOLD and ATS/ERS defined COPD. None of 
the categories in pack years made a significant contribution to the models in univariate 
analyses, and were therefore not included in further analyses, since smoking status was 
selected as predictor. The models contained the following covariates; sex, age, domestic 
exposure, occupational exposure, smoking status and socioeconomic position. When 
containing all predictors, both models were statistically significant, with χ² (7, N=326) = 
43,93, p < 0,0005 when GOLD defined COPD was dependent variable, and χ² (7, N = 326) = 
21,17, p = 0,004 when using the ATS/ERS defined COPD prevalence. The models correctly 
classified 88,7 % (GOLD defined COPD) and 92,0 % (ATS/ERS defined COPD) of the cases. 
The following independent variables made a statistically significant contribution to the GOLD 
defined COPD model; being ex-smoker, (p = 0,01), and age (p < 0,0005). The strongest 
predictor was ex-smoker, with an OR of 5,37. When the ATS defined COPD was dependent 
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variable, ex-smoker was still significant (p = 0,004) with an OR of 7,92. In addition, domestic 
exposure made a statistically significant contribution (p = 0,013). However, the OR was less 
than 1 (0,19), indicating a negative association. As the logistic regression was not adjusted for 
complex sampling, the precision of the OR estimates assumes simple random sampling. The 
odds ratios with their corresponding p-values and 95 % confidence intervals are presented in 
table 8.  
 
 Discussion 
This paper has aimed to estimate prevalence of respiratory symptoms and COPD, defined 
according to both adjusted GOLD and ATS criteria, from a sample of the general adult 
population in Dar Es Salaam, Tanzania.  
 
The prevalence of respiratory symptoms is high among the study participants, with 26,4 % of 
men and 35,0 % of women reporting that they usually cough. Similarly, usually phlegm is 
recorded in 25,2 % and 32,0 % in men and women respectively. Also 22,0 % of men and  
19,9 % of women responded that they have had/ have problems with wheezing. There are no 
previous studies on respiratory symptoms in the general population from Sub-Saharan Africa, 
but when compared to Mokoetle’s respiratory survey of a workforce in Johannesburg, the 
presence of respiratory symptoms among the study participants were also considerable and of 
similar magnitude (15). So far, mainly studies within occupational medicine have investigated 
the prevalence of respiratory symptoms, and how they are related to certain occupational 
pollutants and exposures (16, 17, 18). The burden of respiratory symptoms in the general 
population, beyond a specific workforce, should be paid more attention to in future research.     
 
A limitation of our study is that COPD is diagnosed on basis of simple spirometry, though 
responses to a post-bronchodilator spirometric test and assessment of reversibility of airway 
obstruction are considered a necessity in diagnosing COPD (2, 3). However, due to limited 
resources and the nature of the data collection, it was not feasible to include post 
bronchodilator spirometry as part of the testing. Besides increased costs, transportation and 
storage demands, this would also imply a more elaborate training of assistants as well as a 
more time-consuming test procedure for the study participants.  
In any case, one can question whether the prevalence of COPD in our study consists of truly 
positive COPD cases, as the diagnostic method used fails to discriminate between subjects 
who are responsive and non responsive to a bronchodilator and thus possibly insufficient in 
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differentiating COPD from asthma. According to a Norwegian study by Lehmann et al, a 
reversibility response of FEV1 increase ≥ 12 % and ≥ 200 ml after administration of a 
bronchodilator, was found in 2 % and 4 % of middle-aged (47-48 years) and elderly (71-73 
years) participants respectively (19). Thus only a small fraction of the study population had a 
clinical relevant bronchodilatation after inhalation of salbutamol. This indicates that the 
proportion of possibly false positive COPD cases in our study might not be considerable. 
However, Lehmann did not investigate the reversibility response among those of younger age. 
In any case, the subjects classified as having COPD in our study, had a clear obstructive 
ventilatory pattern, and all of the subjects were in their habitual condition at the time of 
testing, which we consider relevant for the diagnosing, despite the lack of a post-
bronchodilator test. GOLD acknowledges in its report that epidemiological field works face 
challenges in quantifying prevalence and assessing diagnosis and severity of COPD, and 
emphasizes that in areas lacking access to state-of-the-art diagnostic tools, diagnosis should 
be made with the equipment available (212). This helps justify the diagnostic approach used in 
the present study.  
One of the strengths of our study is that the spirometric testing was carried out by use of high- 
quality apparatus, and that strict adherence to ATS/ERS acceptability criteria were followed 
when assessing the manoeuvres. As the testing was conducted out-door in the field, the test 
devices were carried from house to house, and robust equipment, suitable for this setting was 
used. This might have influenced on the accuracy of the data obtained. In future research, it 
would be preferable to have a stationary test lab, where adherence to gold standards within 
test procedures is made easier as the testing is less prone to environmental influences.   
However, training and supervision of field assistants and use of a standardized test procedure 
throughout the data collection have been ensured, hopefully reducing the influence of 
measurement errors.   
 
The prevalence of COPD when applying the fixed cut off ratio of 0.73, was 12,6 %, a 
thought-provoking number as the study population is young, with median age of 37 and 34 for 
men and women respectively. When using the lower limit of normal, prevalence of COPD 
was 7,9 %. The latter method pays attention to the relation between age and lung volumes, 
and the bias of over-diagnosing COPD in the elderly and vice versa among younger adults is 
reduced (9, 20). In our study, the consequences of using GOLD versus ATS criteria when 
                                                 
12
 GOLD report, page 89 
 58
defining COPD cases were not too evident, though the prevalence calculated when applying 
the lower limit of normal was lower compared to when GOLD’s fixed FEV1/FEV6 ratio was 
used. We would anticipate that the age effect and the possibly bias of misclassifying COPD in 
both elderly and younger participants when using GOLD criteria would have been more 
evident if our study sample had been larger.  
 
In any case, irrespective of the method used, the prevalence of COPD is surprisingly high. 
There are no previous studies in East Africa on prevalence of COPD, but according to the 
BOLD study, their site in Cape town, South Africa revealed an overall prevalence rate of 
stage I and stage II COPD at 4,7 % and 12,4 % respectively (11). This was the highest 
numbers of COPD reported in that study. The BOLD study used post-bronchodilator values 
when assessing COPD and in classification of disease severity (4). The authors also found that 
risk factors like smoking and occupational exposures were significant, and that prevalence of 
morbidities like prior tuberculosis was high. In our study, prevalence of stage I and II COPD 
was 6,1 % and 5,8 % respectively.  
Our study showed a statistically significant between being ex-smoker and having COPD. No 
such association could be traced between current smoking and COPD. This finding might 
reflect that former smokers could have stopped smoking because of respiratory symptoms and 
airflow obstruction. Current smokers might not yet have developed obstructive lung disease, 
maybe due to a “healthy worker effect”. The study failed to show a significant relationship 
between occupational exposure and COPD. There might be several explanations to this 
finding. Firstly, the reliability of the information collected on occupational exposure is poor. 
There was a high missing rate (26 %) on questions regarding these issues. People who are 
actively employed tend to have a more favorable health than the population at large, and those 
chronically ill and disabled are naturally excluded from being part of a workforce. This is 
known as the healthy worker effect, and could partly explain the non-significant association 
between occupational exposure and COPD.  
We have no obvious explanation to our finding that domestic exposure seems to be negatively 
associated with COPD. The term “domestic exposure” was calculated based on answers to 
different questions, and the construct might not have captured the true exposures. The 
reliability of the predictor “domestic exposure” could therefore be questionable. In addition, 
the sample size was calculated with the purpose of determining prevalence of COPD, and the 
study might therefore not have enough power to detect any differences between sub-groups. 
Neither of the regression models was adjusted for complex sampling, thus the precision of the 
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estimates presupposes simple random sampling. The odds ratios with their corresponding p-
values and 95 % confidence intervals should therefore be interpreted wit caution.  
The prevalence of current smoking among the study participants must be considered 
disturbingly high among men (30,2 %). This should be given more attention in future 
research, as it has important implications concerning the health status and the expatiation of 
non-communicable diseases in the population in Dar Es salaam, Tanzania.  
 
 The diagnostic tools used to assess respiratory symptoms and conditions among the study 
participants, might have limitations. The feasibility of the ATS-DLD questionnaire to obtain 
information regarding respiratory symptoms in this population must be considered, where 
both meaning and phrasing of words and illnesses are rooted in a different cultural context 
and might not capture the true picture of the study participants interviewed. Developing 
culture specific questionnaires assessing respiratory symptoms and illness should be 
prioritised in future research. Also, the possible presence of response bias must be considered. 
As the questionnaires were both elaborate and time consuming, the bias known as satisficing, 
and the way the respondents are administrating the questionnaire, might reduce the validity of 
the recorded data. However, as the questionnaires were administered face to face by research 
assistants, there is an immediate opportunity to clear up misconceptions on the part of the 
respondent and this might reduce the risk of invalid responses. One must also question the 
validity of questions regarding presence of respiratory illnesses as emphysema, which 
requires diagnostic tools as x-ray or whole body pletysmography to verify. Also presence of 
asthma should be determined based on spirometric testing. Thus reporting of prevalence of 
emphysema (1,9 % and 1,0 % in men and women respectively), and cases of asthma 
(recorded in 10,7 % of men and 10,2 % of women) should be interpreted with caution as it 
might not reflect the true picture in the population. 
  
Some further limitations of the present study need to be considered. The study sample was 
selected randomly, through a multistage cluster technique. However, difficulties in obtaining 
a correct sampling frame prior to the selection, and thus ensuring selection probabilities 
proportionate to size at the different stages, may limit the extent to which the study results can 
be generalised. Due to time and capacity restraints, the two last clusters were not visited. This 
could also have implications on the generalisability of the study outcomes and increase the 
overall sampling error though unlikely to be of significant magnitude.   
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Our study did not seem to identify expected determinants for development of COPD. Still the 
study provides valuable information regarding pulmonary symptoms and obstructive 
pulmonary disease in a population sample of Dar Es Salaam, and it puts respiratory health on 
the agenda. Increased awareness, and more attention to causal relations of COPD are 
important steps towards developing strategies for both prevention and treatment of COPD in 
accordance with the local epidemiological context, and should be prioritized in future 
research. 
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Table 1 
 
Table sociodemographic characteristics. Presented in frequencies and percentages  
Age categories, years  
 
     Total (n = 365) 
   N                 (%)  
      Men (n = 159) 
   N                  (%)  
   Women (n = 206 ) 
   N                    (%)  
 
<20 
 
20-29 
 
30-39 
 
40-49 
 
50-59 
 
60-69 
 
70-79 
 
80+ 
 
 
  47              (12,9)     
 
121              (33,2)   
 
  81              (22,2)     
 
  48              (13,2)     
 
  40              (11,0)     
  
  23              (6,3)      
 
   4               (1,1)        
  
   1               (0,3)        
 
  14                 (8,8)      
 
  49                 (30,8)    
  
  40                 (25,2)    
 
  25                 (15,7)    
 
  16                 (10,1)    
 
  12                 (7,5)      
  
    3                 (1,9)        
 
   
 
  33                   (16,0)     
 
  72                   (35,0)     
 
  41                   (19,9)     
 
  23                   (11,2)     
  
  24                   (11,7)     
 
  11                   (5,3)        
 
    1                   (0,5)         
 
    1                   (0,5 %)     
Job categories * 
 
White collar/professional 
 
Agriculture 
 
Sales/shop keeping 
 
Blue collar 
 
Student 
 
Housewife/house girl 
     Total (n = 269) 
 
  25              (9,3)     
 
  78             (29,0)   
 
  51             (19,0)   
 
  60             (22,3)   
 
  25             (9,3)     
 
 
         Men (n = 121) 
 
  16                (13,2)      
 
  31                (25,6)     
 
  21                (17,4)      
 
  42                (34,7)     
 
  11                (9,1)       
    Women (n = 148) 
 
   9                    (6,1)       
 
  47                   (31,8)   
 
  30                   (20,3)   
 
  18                   (12,2)   
 
  14                   (9,5)     
 
  29                   (19,6)   
  
Level of education,  
 
Never school 
 
Primary level 
 
Secondary level 
 
Advanced secondary 
 
Tertiary 
 
   Total (n = 365) 
 
  39            (10,7)    
 
 210           (57,5)  
 
  96            (26,3)   
 
    7            (1,9)       
 
  13            (3,6)     
     Men (n = 159) 
 
   7                (4,4)         
 
  91               (57,2)     
 
  47               (29,6)     
 
   4                (2,5)         
 
  10               (6,3)       
    Women (n = 206) 
 
  32                   (15,5)     
 
 119                  (57,8)   
 
  49                   (23,8)    
 
    3                   (1,5)       
 
    3                   (1,5)       
 
 
Low SEP index 
Total (n = 365) 
 
90              (24,7) 
Men (n = 159) 
 
29                 (18,2) 
Women (n = 206) 
 
61                     (29,6)  
 
N = number of respondents. % = proportion of respondents. SEP = socioeconomic position 
* non response rate 26 % 
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Table 2 
 
Table; frequency (%) of respiratory symptoms. Presented with 95 % confidence intervals* 
              Men (n = 159)                 Women (n = 206) Symptoms 
 N      (%)                        95 % CI N      (%)                       95 % CI 
 
Usually cough 
 
Cough more than 5 
months during year 
in last 2 years 
 
Usually phlegm 
 
Phlegm more than 3 
months during year 
in last 2 years 
 
Ever wheeze 
 
Wheezing attack 
 
Breathless walking 
 
Need to stop for 
breath at own pace 
 
Need to stop for 
breath after few 
minutes walk 
 
42     (26,4)              20,6 % – 33,2 %  
 
8       (5,0)                2,4 % - 10,3 % 
 
 
 
40     (25,2)             18, 8 % - 32,8 %  
 
8       (5,0)                2,4 % - 10,4 % 
 
 
 
35     (22,0)             14,2 % - 32,5 % 
 
19     (11,9)             7,5 % - 18,6 % 
 
30    (18,9)              12,5 % - 27,5 % 
 
19    (11,9)              7,8 % - 18,0 % 
 
 
13    (8,2)                4,9 % - 13,4 % 
 
72     (35,0)              28,8 % - 41,6 % 
 
7       (3,4)                1,7 % - 6,5 % 
 
 
 
66     (32,0)              26,9 % - 37,7 % 
 
8       (3,9)                1,7 % - 6,5 % 
 
 
 
41     (19,9)              15,8 % - 24,7 %  
 
26     (12,6)              8,6 % - 18,2 % 
 
65     (31,6)              24,6 % - 39,4 % 
 
40     (19,4)              14,1 % - 26,1 % 
 
 
21     (10,2)              6,6 % - 15,4 % 
N =, number of respondents; % = proportion of respondents; CI = confidence interval 
*Adjusted for complex sampling 
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Table 3 
 
Table; frequency (%) of respiratory illnesses. Presented with 95 % confidence intervals* 
                 Men (n = 159)                  Women (n = 206) Condition 
 N        (%)                    95 % CI N        (%)                     95 % CI 
 
Lung trouble before 
the age of 16 
 
Usually chest colds 
 
 
Chest illnesses past 
3 years 
 
Bronchitis 
confirmed by a 
doctor 
 
Pneumonia 
confirmed by a 
doctor 
 
Hayfever confirmed 
by a doctor 
 
Ever chronic 
bronchitis 
 
Ever emphysema 
 
 
Ever asthma 
 
 
Ever tuberculosis 
 
14     (8,8)              5,0 % - 14,9 % 
 
 
32     (20,1)            12,6 % - 30,6 % 
 
 
31     (19,5)             13,1 % - 28,0 % 
 
 
9       (5,7 )               2,2 % - 13,9 %  
 
 
 
17     (10,7)              6,1 % - 18,1 % 
 
 
 
9      (5,7)                 2,9 % - 10,9 % 
 
 
2      (1,3)                 0,2 % - 9,0 % 
 
 
3      (1,9)                 0,7 % - 5,0 % 
 
 
17    (10,7)               5,9 % - 18,5 % 
 
 
6      (3,8)                 1,3 % - 10,4 %         
 
26     (12,6)              9,3 % - 16,9 % 
 
 
55     (26,7)              20,9 % - 33,4 % 
 
 
36     (17,5)              11,1 % - 26,4 % 
 
 
25     (12,1)              7,2 % - 19,8 %   
 
 
 
30     (14,6)              9,0 % - 22,7 % 
 
 
 
21     (10,2)              5,7 % - 17,5 % 
 
 
7       (3,4)                1,6 % - 7,3 % 
 
 
2       (1,0)                0,1 % - 7,3 %    
 
 
21     (10,2)              6,8 % - 15,0 %  
 
 
3       (1,5)                0,5 % - 4,5 %  
N = number of respondents; % = proportion of respondents; CI = confidence interval 
*Adjusted for complex sampling 
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Table 4 
 
Table; Smoking history and burden. Presented with 95 % confidence interval* 
 
Smoking status, N (%) 
  
Never smoker, 
Ex-smoker 
Current smoker 
 
 
Pack-year ex-smoker  
M, 95 % CI 
 
Pack-year categories ex-s 
N (%) 
<1 
1-9,99 
10 and above 
 
 
Pack-year current smoker 
M, 95 % CI 
 
Pack-year categories cu-s 
N (%) 
<1 
1-9,99 
10 and above 
Total (n = 365) 
 
 
297 (81,4) 
17 (4,7) 
51 (14,0) 
 
Total (n = 17**) 
 
6,44        -2,59 – 15,47 
 
 
 
5 (29,4) 
10 (58,8) 
2 (4,8) 
 
Total (n = 51) 
  
8,61       5,67 – 11,56 
 
 
 
8 (15,7) 
26 (51,0) 
17 (33,0) 
Men (n = 159) 
 
 
97 (61,0) 
14 (8,8) 
48 (30,2) 
 
Men (n = 14**) 
 
7,51       -2,76 – 17,77 
 
 
 
3 (21,4) 
9 (64,3) 
2 (14,3) 
 
Men (n = 48) 
 
8,74       5,61 – 11,88 
 
 
 
8 (16,7) 
24 (50,0) 
16 (33,3) 
Women (n = 206) 
 
 
200 (97,1) 
3 (1,5) 
3 (1,5) 
 
Women (n = 3**) 
 
1,47       -0,46 – 3,39 
 
 
 
2 (66,7) 
1 (33,3) 
 
 
Women (n = 3**) 
 
6,55       0,27 – 12,83 
 
 
 
 
2 (66,7) 
1 (33,3) 
 
N = number of respondents. % = proportion of respondents. M = mean. CI = confidence interval.  
* Adjusted for complex sampling ** Inference difficult due to few observations 
 
 
Table 5 
 
Table; Exposure to occupational or domestic pollutants 
 
 
Occupational exposure of 
dust, gas or chemical 
pollutants  
N (%)  
 
Domestic exposure of 
biogas and charcoal 
N (%) 
 
Total (n = 365) 
 
24 (6,6) 
 
 
 
 
108 (29,6 
Men (n = 159) 
 
22 (13,8) 
 
 
 
 
48 (30,2) 
 
 
 
 
Women (n = 206) 
 
2 (1,0) 
 
 
 
 
60 (29,1) 
 
 
 
No, number of respondents; %, proportion of respondents; M, mean; SE, standard error. 
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Table 6 
Table; frequency and proportion of COPD, defined by ATS and GOLD severity stages Presented with 95 % CI* 
 
 
COPD FEV1/FEV6<0.73  
N (%), 95 % CI 
 
Total (n = 32613) 
 
41 (12,6)  8,8 % – 17,6 % 
Men (n=144) 
 
20 (13,9)  9,0 % - 20,9 % 
Women (n = 182) 
 
21 (11,5)  8,0 % - 16,4 % 
COPD LLN 
N (%), 95 % CI 
29 (7,9)  5,2 % – 11,9 % 11 (6,9)  3,6 % - 12,9 % 18 (8,7)  5,6 % - 13,3 % 
GOLD, N (%) 95 % CI 
 
GOLD stage 1 
 
 
GOLD stage 2 
 
GOLD stage 3 
 
GOLD stage 4 
 
 
 
20 (6,1)    3,8 % - 9,7 % 
 
 
19 (5,8)    3,8 % – 8,9 % 
 
1 (0,3)      0,0 % - 2,4 % 
 
1 (0,3)      0,0 % - 2,4 % 
 
 
8 (5,6)      2,8 % - 10,8 % 
 
 
11 (7,6)    4,6 % - 12,4 % 
 
 
 
1 (0,7)      0,1 % - 5,4 %  
 
 
12 (6,6)    3,7 % - 11,4 % 
 
 
8 (4,4)      2,3 % - 8,1 %  
 
1 (0,5)       0,1 % - 4,2 % 
N = number of respondents, % = proportion of respondents, CI = Confidence Interval, LLN=Lower Limit of 
Normal 
* Adjusted for complex sampling 
 
 
 
 
 
Table 7 
 
Table; age distribution of frequency and proportion of GOLD defined COPD and ATS defined COPD 
Age categories COPD (GOLD) (n = 41) 
N (%)               95 % CI* 
COPD (ATS) (n = 29) 
N (%)           95 % CI 
 
<20 
 
20-29 
 
30-39 
 
40-49 
 
50-59 
 
60-69 
 
70 + 
 
 
9 (8,6)              5,0 % - 14,2 % 
 
4 (5,5)              1,5 % - 17,7 % 
 
6 (13,0)            8,1 % - 20,4 % 
 
11 (31,4)          16,6 % - 51,4 % 
 
9 (40,9)            25,1 % - 58,9 % 
 
2 (50,0)            10,4 % - 89,6 %                   
1 (2,4)          0,3 % - 16,8 %   
 
11 (10,5)      5,6 % - 18,7 % 
 
2 (2,7)          0,3 % – 20,6 %  
 
4 (8,7)          4,4 % - 16,6 % 
 
6 (17,1)        8,3 % - 32,1 % 
 
5 (22,7)        8,3 % - 32,1 % 
 
N = number of respondents, % = proportion of respondents, CI = confidence interval 
*Adjusted for complex sampling 
 
 
 
 
 
                                                 
13
 Denominator includes only subjects with acceptable spirometry 
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Table 8 
Table; Logistic regression. Determinants of COPD (defined by GOLD and ATS).  
Presented with OR and 95 % CI* 
Determinants 
 
 
Sex 
 
Age 
 
Ex-smoker 
 
Current smoker 
 
Domestic exposure 
 
Occupational exposure 
 
SEP 
 
 COPD   (GOLD) 
p              OR       95 % CI for OR    
 
0,55         1,30      0,55 – 3,09 
 
<0,0005   1,06      1,04 – 1,09 
 
0,011        5,37      1,46 – 19,71 
 
0,24          1,85      0,66 – 5,15 
 
0,11          0,48      0,20 – 1,17  
 
0,56          1,45      0,42 – 4,98 
 
0,82          1,10      0,48 – 2,54 
COPD   (ATS) 
p              OR       95 % CI for OR 
 
0,28         1,71      0,64 – 4,54 
 
0,09         1,02      1,00 – 1,05 
 
0,004       7,92       1,91 – 32,76 
 
0,85         0,87       0,21 – 3,59 
 
0,013       0,19       0,05 – 0,71 
 
0,57         1,57       0,33 – 7,41 
 
0,52         0,75       0,31 – 1,82     
OR= Odds Ratio. CI= Confidence Interval. p = p-value. SEP= Socioeconomic position 
* Not adjusted for complex sampling 
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Figure 1; scatter plots of COPD cases versus healthy among men defined by GOLD  
plotted against age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2; scatter plots of COPD cases versus healthy among men defined by ATS  
plotted against age. Lower limit of normal highlighted  
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Figure 3; scatter plots of COPD cases versus healthy among women defined by GOLD 
Plotted against age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 4; scatter plots of COPD cases versus healthy among women defined by ATS 
against age. Lower limit of normal highlighted 
 
 
 
 
 
 
Appendix 1 
ATS-DLD questionnaire                           
 ATS-DLD-78-A                                 | 
|                   ADULT QUESTIONNAIRE - SELF COMPLETION                     | 
|                   (for those 13 years of age and older)                     | 
Thank you for your willingness to participate.  You were selected by a scientific sampling procedure, and your 
cooperation is very important to the success of this study.                                   This is a questionnaire you are 
asked to fill out.  Please answer the questions as frankly and accurately as possible.   
ALL INFORMATION  OBTAINED IN THE STUDY WILL BE KEPT CONFIDENTIAL AND USED FOR 
MEDICAL RESEARCH ONLY.  Your personal physician will be informed about the test results if you desire.                                                    
| 
|-----------------------------------------------------------------------------| 
                              IDENTIFICATION 
 
            IDENTIFICATION NUMBER: ##### 
 
            NAME:_________________________  ________________________  ___ 
                          (Last)                     (First)         (MI) 
 
            STREET ______________________________________________________ 
 
            CITY ____________________________   STATE  ____  ZIP  _______ 
 
            PHONE NUMBER: (    ) ______-__________ 
 
            INTERVIEWER: ### 
 
            DATE: ___________________ 
                    MO    DAY    YR  
 
  
 1.  BIRTHDATE: _____  ____  ______ 
                 Month   Day   Year 
 
  2.  Place of Birth: _______________________________ 
 
  3.  Sex:                            1. Male ____ 
                                      2. Female ____ 
 
  4.  What is your marital status?    1. Single ____ 
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                                      2. Married ____ 
                                      3. Widowed ____ 
                                      4. Separated/Divorced ____ 
 
  5.  Race:                           1. White ____ 
                                      2. Black ____ 
                                      3. Oriental ____ 
                                      4. Other ____ 
 
  6.  What is the highest grade completed in school? __________ 
      (For example: 12 years is completion of high school) 
 
                                 SYMPTOMS 
  These questions pertain mainly to your chest.  Please answer yes or no if possible.  If a question does not appear 
to be applicable to you, check the “does not apply” space.  If you are in doubt about whether your answer is yes 
or no, record no. 
 
  COUGH 
 
  7A. Do you usually have a cough?                         1. Yes ___ 2. No ___ 
      (Count a cough with first smoke or on first going 
      out-of-doors.  Exclude clearing of throat.)[If no, 
      skip to question 7C.] 
 
   B. Do you usually cough as much as 4 to 6 times a       1. Yes ___ 2. No ___ 
      day, 4 or more days out of the week? 
 
   C. Do you usually cough at all on getting up, or        1. Yes ___ 2. No ___ 
      first thing in the morning? 
 
   D. Do you usually cough at all during the rest          1. Yes ___ 2. No ___ 
      of the day or at night? 
 
   IF YES TO ANY OF THE ABOVE(7A,7B,7C, OR 7D), ANSWER THE FOLLOWING: 
   IF NO TO ALL, CHECK DOES NOT APPLY AND SKIP TO 8A. 
 
   E. Do you usually cough like this on most days for      1. Yes ___ 2. No ___ 
      5 consecutive months or more during the year? 
                                                           8. Does not apply __ 
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   F. For how many years have you had this cough?          ____________________ 
                                                             Number of years    
                                                          88. Does not apply __ 
 
 
 PHLEGM 
 
  8A. Do you usually bring up phlegm from your chest?      1. Yes ___ 2. No ___ 
      (Count phlegm with the first smoke or on first 
      going out-of-doors.  Exclude phlegm from the 
      nose.  Count swallowed phlegm) 
      [If no, skip to 8C.] 
 
   B. Do you usually bring up phlegm like this as          1. Yes ___ 2. No ___ 
      much as twice a day, 4 or more days out of the week? 
 
   C. Do you usually bring up phlegm at all on get-        1. Yes ___ 2. No ___ 
      ting up or first thing in the morning? 
 
   D. Do you usually bring up phlegm at all during         1. Yes ___ 2. No ___ 
      the rest of the day or at night? 
 
   IF YES TO ANY OF THE ABOVE (8A, B, C, OR D), 
   ANSWER THE FOLLOWING: 
   IF NO TO ALL, CHECK DOES NOT APPLY AND SKIP TO 9A. 
 
   E. Do you bring up phlegm like this on most days        1. Yes ___ 2. No ___ 
      for 3 consecutive months or more during the 
      year?                                                8. Does not apply __ 
 
   F. For how many years have you had trouble with         ____________________ 
      phlegm?                                                Number of years    
                                                          88. Does not apply __ 
 
 
    EPISODES OF COUGH AND PHLEGM 
 
  9A. Have you had periods or episodes of (in-             1. Yes ___ 2. No ___ 
      creased*) cough and phelgm lasting for 3 
      weeks or more each year? 
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      *(For individuals who usually have cough and/or 
      phlegm) 
 
        IF YES TO 9A: 
 
   B. For how long have you had at least 1 such episode per year?    _____(Number of years)                                       
                                                          88. Does not apply __ 
 
 
    WHEEZING 
 
 10A. Does your chest ever sound wheezy or whis- 
      tling: 
         1. When you have a cold?                              1. Yes ___ 2. No ___ 
         2. Occaisonally apart from colds?                 1. Yes ___ 2. No ___ 
         3. Most days or nights?                                   1. Yes ___ 2. No ___ 
 
        IF YES TO 1, 2, OR 3 IN 10A: 
 
   B. For how many years has this been present?            ____________________ 
                                                              Number of years 
                                                          88. Does not apply __ 
 
 11A. Have you ever had an ATTACK of wheezing that         1. Yes ___ 2. No ___ 
      has made you feel short of breath?  
 
        IF YES TO 11A: 
 
   B. How old were you when you had your first             _______ Age in years 
      such attack?                                        88. Does not apply __ 
 
   C. Have you had 2 or more such episodes?                1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
    
   D. Have you ever required medicine or treatment         1. Yes ___ 2. No ___ 
      for the(se) attack(s)?                               8. Does not apply __ 
 
 
 
    BREATHLESSNESS 
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 12.  If disabled from walking by any condition 
      other than heart or lung disease, please 
      describe and proceed to Question 14A. 
 
      Nature of condition(s):__________________________________________________ 
 
 13A. Are you troubled by shortness of breath when 
      hurrying on the level or walking up a slight hill?   1. Yes ___ 2. No ___ 
 
        IF YES TO 13A: 
 
   B. Do you have to walk slower than people of your       1. Yes ___ 2. No ___ 
      age on level because of breathlessness?              8. Does not apply __ 
                                                            
   C. Do you ever have to stop for breath when walk-       1. Yes ___ 2. No ___ 
      ing at your own pace on the level?                   8. Does not apply __ 
 
   D. Do you ever have to stop for breath after walk       1. Yes ___ 2. No ___ 
      ing about 100 yards(or after a few minutes) on       8. Does not apply __ 
      the level?  
                  
   E. Are you too breathless to leave the house or         1. Yes ___ 2. No ___ 
      breathless on dressing or undressing?                8. Does not apply __ 
 
 
    CHEST COLDS AND CHEST ILLNESSES 
 
 14A. If you get a cold, does it usually go to your        1. Yes ___ 2. No ___ 
      chest? (Usually means more than 1/2 the time)        8. Don't get colds__ 
 
 15A. During the past 3 years, have you had any            1. Yes ___ 2. No ___ 
      chest illnesses that have kept you off work, in-      
      doors at home, or in bed?  
 
        IF YES TO 15A: 
 
   B. Did you produce phlegm with any of these             1. Yes ___ 2. No ___ 
      chest illnesses?                                     8. Does not apply __ 
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   C. In the last 3 years, how many such illnesses,    _____Number of illnesses 
      with (increased) phlegm, did you have which      _____No such illnesses 
      lasted a week or more?                           _____Does not apply 
 
 
     PAST ILLNESSES 
 
 16.  Did you have any lung trouble before the age         1. Yes ___ 2. No ___ 
      of 16?                                                
 
 17.  Have you ever had any of the following: 
      1A. Attacks of Bronchitis?                           1. Yes ___ 2. No ___ 
                                                                                
        IF YES TO 1A:                                                           
       B. Was it confirmed by a doctor?                    1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       C. At what age was your first attack?               ______ Age in years  
                                                          88. Does not apply __ 
 
      2A. Pneumonia (include bronchopneumonia)?            1. Yes ___ 2. No ___ 
                                                                                
         
IF YES TO 2A:                                                           
       B. Was it confirmed by a doctor?                    1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       C. At what age did you first have it?               ______ Age in years   
                                                          88. Does not apply __ 
 
      3A. Hayfever?                                        1. Yes ___ 2. No ___                    
                                                                                
        IF YES TO 3A:                                                           
       B. Was it confirmed by a doctor?                    1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       C. At what age did it start?                        ______ Age in years  
                                                          88. Does not apply __ 
 
 18A. Have you ever had chronic bronchitis?                1. Yes ___ 2. No ___ 
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        IF YES TO 18A:                                                          
       B. Do you still have it?                            1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       C. Was it confirmed by a doctor?                    1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       D. At what age did it start?                        ______ Age in years  
                                                          88. Does not apply __ 
 
 19A. Have you ever had emphysema?                         1. Yes ___ 2. No ___ 
                                                                                
        IF YES TO 19A:                                                          
       B. Do you still have it?                            1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       C. Was it confirmed by a doctor?                    1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       D. At what age did it start?                        ______ Age in years  
                                                          88. Does not apply __ 
 
 
 20A. Have you ever had asthma?                            1. Yes ___ 2. No ___ 
                                                                                
        IF YES TO 20A:                                                          
       B. Do you still have it?                            1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       C. Was it confirmed by a doctor?                    1. Yes ___ 2. No ___ 
                                                           8. Does not apply __ 
                                                                                
       D. At what age did it start?                        ______ Age in years  
                                                          88. Does not apply __ 
 
       E. If you no longer have it, at what age did it     ______ Age stopped  
          stop?                                           88. Does not apply __ 
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 21.  Have you ever had: 
 
       A. Any other chest illnesses?                       1. Yes ___ 2. No ___ 
            If yes, please specify ____________________________________________ 
          
       B. Any chest operations?                            1. Yes ___ 2. No ___ 
            If yes, please specify ____________________________________________ 
 
       C. Any chest injuries?                              1. Yes ___ 2. No ___ 
            If yes, please specify ____________________________________________ 
 
 22A.  Has doctor ever told you that you had heart         1. Yes ___ 2. No ___ 
       trouble?   
 
          IF YES to 22A: 
 
       B. Have you ever had treatment for heart trouble    1. Yes ___ 2. No ___ 
          in the past 10 years?                            8. Does not apply __ 
 
 23A.  Has a doctor ever told you that you have high       1. Yes ___ 2. No ___ 
       blood pressure? 
 
          IF YES to 23A: 
  
       B. Have you had any treatment for high blood        1. Yes ___ 2. No ___ 
          pressure (hypertension) in the past 10 years?    8. Does not apply __ 
 
 
     OCCUPATIONAL HISTORY 
 
 24A.  Have you ever worked full time (30 hours per        1. Yes ___ 2. No ___ 
       week or more) for 6 months or more? 
 
          IF YES to 24A: 
  
       B. Have you ever worked for a year or more in       1. Yes ___ 2. No ___ 
          any dusty job?                                   8. Does not apply __ 
 
          Specify job/industry: _________________________ Total years worked __ 
          Was dust exposure  1. Mild ___   2. Moderate ___  3. Severe ___ ? 
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       C. Have you ever been exposed to gas or chemical    1. Yes ___ 2. No ___ 
          fumes in your work?                              8. Does not apply __ 
 
          Specify job/industry: _________________________ Total years worked __ 
          Was dust exposure  1. Mild ___   2. Moderate ___  3. Severe ___ ? 
 
       D. What has been your usual occupation or job -- the one you have 
          worked at the longest? 
 
          1. Job-occupation: __________________________________________________ 
          2. Number of years employed in this occupation:______________________ 
          3. Position-job title: ______________________________________________ 
          4. Business, field, or industry: ____________________________________ 
 
 
                             TOBACCO SMOKING 
 
 25A.  Have you ever smoked cigarettes? (NO means          1. Yes ___ 2. No ___ 
       less than 20 packs of cigarettes or 12 oz. of 
       tobacco in a lifetime or less than 1 cigarette a 
       day for 1 year. 
 
          IF YES to 25A: 
 
       B. Do you now smoke cigarettes (as of 1 month       1. Yes ___ 2. No ___ 
          ago)?                                            8. Does not apply __ 
 
       C. How old were you when you first started reg-        ____ Age in Years 
          cigarette smoking?                               88.Does not apply __ 
                
       D. If you have stopped smoking cigarettes com-         ____ Age stopped 
          pletely, how old were you when you stopped?         Check if 
                                                              still smoking ___ 
                                                           88.Does not apply __ 
       E. How many cigarettes do you smoke per day now?    ___ Cigarettes/day 
                                                           88.Does not apply __ 
 
       F. On the average of the entire time you smoked,    ___ Cigarettes/day 
          how many cigarettes did you smoke per day?       88.Does not apply __ 
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       G. Do or did you inhale the cigarette smoke?        1. Does not apply __ 
                                                           2. Not at all ______ 
                                                           3. Slightly ________ 
                                                           4. Moderately ______ 
                                                           5. Deeply __________ 
 
 26A.  Have you ever smoked a pipe regularly?              1. Yes ___ 2. No ___ 
       (YES means more than 12 oz tobacco in a 
       lifetime.) 
 
          IF YES to 26A: 
 
       B1. How old were you when you started to               ____ Age 
           smoke a pipe regularly? 
 
        2. If you have stopped smoking a pipe com-            ____ Age stopped 
           pletely, how old were you when you stopped?        Check if still 
                                                              smoking pipe ____ 
                                                           88.Does not apply __ 
 
       C. On the average over the entire time you    ____ oz per week (a stan-  
          smoked a pipe, how much pipe tobacco did  dard pouch of tobacco con-  
          you smoke per week ?                      tains 1 1/2 oz)             
                                                           88.Does not apply __ 
 
       D. How much pipe tobacco are you smoking now?           ___ oz per week  
                                           88. Not currently smoking a pipe ___ 
 
       E. Do or did you inhale the pipe smoke?             1. Never smoked ____ 
                                                           2. Not at all ______ 
                                                           3. Slightly ________ 
                                                           4. Moderately ______ 
                                                           5. Deeply __________ 
 
 
 27A.  Have you ever smoked cigars regularly?              1. Yes ___ 2. No ___ 
       (Yes means more than 1 cigar a week for a 
       year). 
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          IF YES to 27A: 
      
       B1. How old were you when you started smok-            ____ Age 
           ing cigars regularly? 
 
        2. If you have stopped smoking cigars com-            ____ Age stopped 
           pletely, how old were you when you stopped?        Check if still 
                                                              smoking cigars___ 
                                                           88.Does not apply __ 
 
       C. On the average over the entire time you           ___ Cigars per week 
          smoked cigars, how many cigars did you smoke     88.Does not apply __ 
          per week ? 
 
       D. How many cigars are you smoking per week          ___ Cigars per week 
          now?                     88. Check if not smoking cigars currently __ 
 
       E. Do or did you inhale the cigar smoke?            1. Never smoked ____ 
                                                           2. Not at all ______ 
                                                           3. Slightly ________ 
                                                           4. Moderately ______ 
                                                           5. Deeply __________ 
 
 
     FAMILY HISTORY 
 
 28.  Were either of your natural parents ever told by a doctor that they 
      had a chronic lung condition such as: 
 
                            FATHER                          MOTHER 
 
                    1. YES   2. NO   3. DON'T       1. YES   2. NO   3. DON'T 
                                        KNOW                            KNOW 
 
 
    A. Chronic 
       brochitis?   _____    _____   _______        _____    _____   _______ 
       
    B. Emphysema?   _____    _____   _______        _____    _____   _______ 
       
- 82 - 
 
    C. Asthma?      _____    _____   _______        _____    _____   _______ 
       
    D. Lung cancer? _____    _____   _______        _____    _____   _______ 
       
    E. Other chest  
       conditions?  _____    _____   _______        _____    _____   _______ 
 
 
 
 29A.  Is parent currently alive? 
                    _____    _____   _______        _____    _____   _______ 
 
    B. Please Specify: 
 
                    _____ Age if living             _____ Age if living 
 
                    _____ Age at death              _____ Age at death 
 
                  8. Don't know _____             8. Don't know _____ 
 
    C. Please specify cause of death. 
         ________________________________          _________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 83 - 
 
 
Appendix 2 
Questionnaire, socioeconomic conditions  
 
1 Level of Education: Please tick appropriate box 
 
Never attended school  1 
Primary level education  2  
 
Secondary level education  3 
 
Advanced secondary school (High Level)  4  
 
Tertiary education, including undergraduate and diploma level  5 
 
Higher advanced learning = masters and PHD programmes  6 
 
 
2. Question  
a) Are you employed? 
Yes 1 Go to questions 8b and 8c 
No 2 Go to question 9 
 
b) Where do you work? _____________ 
c) What is your position there? ______________  
 
3. In the past 7 days have you had any work for pay? 
Yes 1 Go to question 10 
No 2 Skip to question 11 
 
4 What kind of work was it? ________________________  
5. When was the last time that you worked for money? 
Within the last month 1 
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Within the last 3 months 2 
Over six months ago 3 
 
6. In the past 10 days have you had money available from other sources than work? 
Yes 1 Go to question 11 
No 2 Skip to question 12 
 
7. What are the sources___________? 
8. What is the number of people living in the household (excluding visitors)? ________ _____ 
9. Who is the head the household? Male or female _____________ 
10. What is the main source of drinking water for members of your household? 
Piped 1 
 
In 
residence 1 
Outside 
residence 2 
Public tap 
3 
Open well 2  In yard/plot 1 Outside yard 2   
Protected well 3  In yard/plot 1 Outside yard 2   
Borehole 4  In yard/plot 1 Outside yard 2   
Spring water 5        
Rain water 6        
Tanker truck water 7        
River, canal or surface water 8 
       
Bottled water 9        
Water from gravity flow scheme 10 
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11. What Type of toilet does your household have? 
Flush toilet (own) 1 
Flush toilet (shared with other household) 2 
Traditional pit toilet/ latrine 3 
Ventilated improved pit latrine 4 
No facility/ Bush/ Field 5 
Other : Please specify______________ 6 
 
12. Please indicate by ticking if your household has: 
Electricity 1 
Radio 2 
Television 3 
Telephone (fixed ) /( mobile) 4 
Refrigerator 5 
Lantern 6 
Cupboard 7 
 
 
13. What is the principal flooring material in your house? 
Earth/ dirt/sand/dung 1 
Cement 2 
Vinyl or asphalt tile 3 
Ceramic tiles 4 
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Parquet or polished wood 5 
Other, please specify_______________ 6 
 
14. What is the main material in the walls? 
Thatched 1 
Mud and pole 2 
Un burnt bricks 3 
Burnt bricks with mud 4 
Burnt bricks with cement 5 
Timber 6 
Cement blocks, bricks, concrete walls 7 
Stone 8 
Other, please specify__________________ 9 
 
15. What is the principal roofing material in your house? 
Thatched 1 
Iron sheets 2 
Asbestos 3 
Tiles 4 
Tin 5 
Cement 6 
Other, please specify_______________ 7 
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16. Does any member of your household own………? 
A bicycle 1 
A motorcycle or motor scooter 2 
A car or truck 3 
A boat or canoe 4 
A donkey 5 
 
17. What do you use for lighting? 
Electricity 1 
Biogas 2 
Kerosene 3 
Charcoal 4 
Dung 5 
Others please specify ______________________  
 
18. Would you say that people in your household often, sometimes, seldom or never go hungry? 
Often 1 
Sometimes 2 
Seldom 3 
Never 4 
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Appendix 3 
Informed consent form 
Informed Consent 
You are being asked to participate in a study assessing lung function for an adult population 
in Kinondoni district, Dar Es Salaam, Tanzania. The aim of the study is partly to establish 
values for normal lung function, and partly to determine the frequency of respiratory 
symptoms and a condition called COPD (Chronic Obstructive Pulmonary Disease), which is 
an astma-like disease. Since there is poor knowledge on how frequent this condition is in 
Tanzania, it is important to collect more information to enable health policy makers to plan 
for intervention strategies.  
We ask you to participate in this study because you are a member of this community, and are 
above the age of 15. 
If you are willing to participate in the proposed study, the information you provide will be 
kept confidential. Your name will not be required, and all tests and answers will be handled 
anonymously. We will request you to blow 3 times in a spirometer(an apparatus that measures 
lung volumes), and we will register your age, and measure your height and weight. Finally we 
want you to answer some questions regarding respiratory symptoms and living conditions. If 
we detect disease that needs medical attention, you will be aided with referral to proper 
medical care.    
Participation in the study is voluntary and free of charge, and you can withdraw at any time, 
also after consenting to participate, without giving any reason. Your answers and test results 
will then be deleted.  
Thank you for your cooperation 
 
Correspondence: 
Toril Morkve Knudsen- Principal investigator 
National Institute for Medical Research 
Muhimbili Research Centre 
Tel 0744 307624 
 
Study participant: 
I have been informed about the nature and aim of the study, and I give my consent to 
participate 
Signature of study participant:……………………………………………. 
Thumb print of study participant: 
Date:………/………/………………………  
 
